Dietary protein and bone health: Harmonizing conflicting theories by Thorpe, Matthew P.
Copyright 2010 Matthew Patrick Thorpe 
 
 
 
 
 
 
DIETARY PROTEIN AND BONE HEALTH: 
HARMONIZING CONFLICTING THEORIES 
 
 
 
 
 
 
BY 
 
MATTHEW PATRICK THORPE 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Nutritional Sciences 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2010 
 
 
 
 
Urbana, Illinois 
 
 
  Doctoral Committee: 
 
  Professor Donald Layman, Chair 
  Associate Professor Ellen Evans, Director of Research 
  Professor John Erdman 
  Professor Karen Chapman-Novakofski 
  Assistant Professor Amy Wagoner Johnson 
ABSTRACT 
 
 No clear consensus on the role of higher protein intakes has emerged, in spite of 
many decades of research. Protein unambiguously increases urinary calcium losses, which is 
completely attributable to the dietary acid load imposed by metabolism of sulfur containing 
amino acids into acid equivalents. Although alternate dietary sources of fixed acid cause 
demineralization of bone and apparent osteoporosis, this effect has not been consistently 
observed for protein, suggesting opposing, beneficial effects on bone. Specifically, protein 
may improve bone health through improving calcium absorption, increasing total circulating 
insulin-like growth factor 1 or by improving lean body mass which in turn increases bone 
growth. Although the notion of competing positive and negative pathways has been 
articulated theoretically, statistical mediation models of this “dual pathways” relationship 
have not been employed to quantify these relationships. 
 In a cross-sectional investigation of postmenopausal women, protein intake is 
positively related to bone mineral density of the lumbar spine following adjustment for an 
accompanying negative effect mediated by the sulfur containing fraction of protein. In 
growing rats, an analogous and complementary pattern emerged: A negative association of 
protein intake with bone strength was suppressed by an opposing, positive effect of protein 
mediated by insulin-like growth factor 1. A second animal study assessed the influence of 
protein source on bone strength and bone mineral content of growing rats consuming 
isoenergetic, isonitrogenous diets. The influence of protein source was completely mediated 
by the corresponding changes in lean body mass. 
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 A randomized, controlled trial indicated a higher protein diet preserved bone density 
during weight loss compared to a conventional, MyPyramid based diet; however the protein 
diet also contained more calcium. A mathematical model of calcium availability in this trial 
suggested that this additional dietary calcium was not sufficient to explain differences in 
calcium accrual between groups unless calcium availability was also improved in the higher 
protein diet. Also, within this study, urine calcium (a surrogate of the diet acid load) 
exhibited a negative association with bone density change, in spite of its positive association 
with protein intake.  
 The striking consistency of a dual pathway model across populations and 
experimental models lends credence to the notion that dietary protein may hold a positive or 
negative effect on bone health, depending on other factors in the diet. Specifically, we find 
support that the sulfur containing amino acid induced dietary acid load holds negative effects 
that may be opposed by positive influences of insulin-like growth factor 1, calcium 
availability or lean body mass. On average, this effect is probably null or too small to be of 
clinical importance.  
The effect may be of public health relevance, however, if the diet can be manipulated 
in order to uncouple positive and negative pathways. If correct, the dual pathway model 
predicts higher protein intakes will have modest benefits on bone health in the context of 
adequate calcium intake, selection of protein sources lower in sulfur amino acids or ample 
intake of fruits and vegetables to buffer the dietary acid load. 
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Chapter 1 
Introduction 
 
 Despite decades of research no clear consensus has emerged on the influence of 
dietary protein on bone health. Early research revealed calcium loss in urine increases in 
proportion to protein intake. The source of this calcium, however, was unclear. Over time, a 
theoretical model emerged positing that a chronic, low-grade acidosis imposed by 
metabolism of sulfur amino acids causes demineralization of bone tissue. This model has 
been supported indirectly by work in animals and isolated tissues; however demineralization 
of bone has not been consistently established in humans in relation to protein intake. 
 More recently it has been determined that calcium becomes more bioavailable at 
higher levels of protein in the diet. Mechanisms for this effect are unknown, but may relate to 
homeostatic compensation for calcium lost in urine, or regulation of endocrine pathways by 
circulating amino acids. In particular, higher protein intakes may suppress circulation of 
bioactive parathyroid hormone and calcitriol, and augment circulation of insulin-like growth 
factor 1, each with well established influences on bone metabolism. Emergent is a concept 
that protein may have a two-faced influence on bone health, acting simultaneously through 
bone-building and bone-destructive pathways. 
 The complexities of apparently contradictory influences of protein on bone health 
have spurred many studies, yielding wildly variable data and leaving the protein-bone 
question murky. Current reviews and meta-analyses determine higher protein intakes impart 
a modest benefit to bone. This summary statement, although accurate on average, masks the 
convoluted state of clinical and epidemiological research identifying occasionally negative, 
commonly null and often positive results. 
1 
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 Throughout this dissertation, I will defend the position that ambiguity in the available 
data reflect, in part, failure of current theoretical (and statistical) models to account for the 
duality of protein's influence on bone. I will promote a model in which the sum total effect of 
dietary protein intake arises from the balance of competing positive and negative paths. 
Although slightly more complex than the hypotheses tested in previous research, this model 
is unique in its ability to bring clarity to an otherwise chaotic body of research.  
 Throughout this dissertation I will compare, unless otherwise indicated, intakes of 
protein that are adequate according to current recommendations to higher levels of protein 
intake. Frank protein insufficiency is well documented to be damaging to bone, and levels 
below 0.8 g protein / kg body weight daily are not at issue here. 
 I will present data from epidemiological, animal and clinical investigations 
supporting the premise that dietary protein has a predictable influence on bone health 
provided that both sides of the dual influence are accounted for. Limitations of these studies 
will be examined, and the strength of the model weighed.  
 If correct, the implication of the dual influence model is that positive and negative 
pathways may be manipulated in order to shift the balance toward a (probably modest) 
benefit to bone health. Specifically, if correct, we would predict that protein will be more 
beneficial where calcium intakes are sufficient to replace urinary losses, where intakes of 
alkalizing nutrients (readily available in fruits and vegetables) neutralize the dietary acid load 
associated with protein, or where protein source is naturally low in acid producing amino 
acids or naturally rich in amino acids promoting growth pathways. In addition, this model 
implies that higher protein diets, though much criticized in the past for a theoretical harm to 
bone, are unlikely to have a substantially detrimental effect in free-living populations. 
Chapter 2 
Dietary protein and bone health: Harmonizing conflicting theories 
 
Introduction 
Argument regarding the relationship between dietary protein and bone health has 
unrolled over more than fifty years. Animal, epidemiological and clinical work have 
corroborated that high protein intakes can impose a small but chronic metabolic acid load (1-
3), and that this acid load may cause bone loss (4-6). Indeed, urinary calcium losses are 
unequivocally induced by high protein intakes (7). In contest, equally diverse research 
paradigms support that dietary protein increases calcium absorption or bioavailability (8-13), 
casting the net effect on the calcium economy into doubt. Furthermore, trials have 
persuasively argued that increased protein may initiate bone anabolism mediated by the 
protein-sensitive insulin like growth factor 1 (IGF-1, 14-16).  
In the midst of so many valid mechanisms for dietary protein to either enhance or 
degrade bone health, a recent meta-analysis (17) observed no overall effect in observational 
studies, excepting a modest benefit to bone mineral density (BMD) of the lumbar spine. Even 
this effect was so small as to be of questionable clinical importance, casting doubt as to 
whether higher protein intakes influence bone at all. 
A newer emerging concept has been that protein does indeed influence bone through 
simultaneous beneficial and detrimental pathways (18). Specifically, it is thought that a 
negative influence of protein’s diet acid load is opposed by increased calcium absorption and 
anabolic influence of IGF-1 (19). The implication of this dual-pathway model is that the net 
influence on bone may be positive, negative or null, depending on additional dietary 
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considerations (19-21). The dual-pathway model is attractive in its capacity to harmonize 
apparently conflicting data, providing a sound theoretical basis to reconcile divergent views. 
In this review, we will summarize the history and current state of the literature of 
dietary protein in urinary calcium loss, intestinal availability, dietary acid load and bone 
turnover. We will attempt to illustrate that no one of these factors is sufficient to explain the 
complex relationship of dietary protein and bone health. Throughout this review, we will 
discuss the influence of protein intakes above the current RDA of 0.8 g protein / kg body 
weight. That protein intakes below this level cause a protein deficient state that is harmful to 
bone is plainly apparent (see 22 for a review), and outside of our present scope.  
If the competing pathways model is correct, we might predict that additional 
manipulations of the diet, such as providing ample calcium or acid-neutralizing foods such as 
fruits and vegetables, may “tip the scales” (23) to a favorable role of protein in bone health. 
Protein and Urine Calcium 
Protein causes urine calcium loss 
 In 1920 HC Sherman, an important figure in early mineral balance research, 
published the observation that adding meat to the diet of a healthy young male increased the 
amount of calcium intake required to maintain equivalence of calcium in and outputs (24). 
Subsequently a consistent elevation of urinary calcium in response to changes in protein 
intake has been found across many human studies. A meta-analysis by Kerstetter et al. (7) 
produced this equation, which explains 49% of the variation in urinary calcium across 26 
studies: 
Urine Ca, mmol/d = (3.208e-2) * protein, g/d + 1.501 eq. 1 
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This equation would predict that a 40 g/d increase in protein intake (roughly equivalent to a 
typical American woman switching from a conventional to a South Beach diet) would 
translate to an additional 50 mg of calcium lost in urine daily. Though small, the 
accumulation of 50 mg/d calcium losses over decades could indeed cause clinically 
significant osteoporosis if this calcium is depleted from roughly 1 kg of skeletal calcium in 
adult humans (25).  
Dietary acid causes urine calcium loss 
 Views on the source of protein induced urinary calcium loss have changed over time. 
Acid-base balance studies by Lemann et al. in the 60s (26) demonstrated that 
supplementation of up to 280 mmol/d ammonium chloride is only partially buffered by 
declining serum bicarbonate and renal net acid excretion, leaving a residual “acid gap” that 
must be accounted for by some alternative buffer source in the body. In subsequent research 
those authors found this acid gap corresponded to an increase in urine calcium losses and, 
ostensibly, negative calcium balance (27). Furthermore, calcium losses were only partially 
recovered following correction of acidosis with supplemented bicarbonate.  
The idea emerged that release of buffer from bone tissue, including bicarbonate and 
phosphate, would accompany the release of calcium observed in the urine, and that exchange 
of acid for this buffer would account for the missing acid (28-30). The “acid-ash” hypothesis 
(28) posited that this buffering action of bone mineral would lead to bone wasting over time, 
contributing to the development of osteoporosis. Acid ash refers to acids remaining after 
combustion of food, which correspond to a fixed acid load in the diet that must be 
compensated by metabolic, rather than respiratory systems (25). Correction of metabolic 
acidosis using supplemental base reduced urine calcium loss to normal levels (31). Since 
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then, the observation that bicarbonate or citrate supplementation reduces urine calcium has 
been replicated in many randomized trials (e.g., 32-36), including over a time span up to 36 
mo (37).  
Dietary protein increases the dietary acid load 
 Dietary protein is a major contributor to the acid ash of the diet (38). In humans this is 
completely attributable to metabolism of sulfur containing amino acids (SAA) to sulfuric 
acid (39). Indeed, renal Net Acid Excretion (NAE), a measure of renal excretion of acid 
equivalents (measured as total urine NH4+ - HCO3- + titratable acid, 40) varies in proportion 
to SAA in the diet (41-44). Schuette et al. (45) report that SAA adequately explained the 
complete difference in NAE in response to protein source. The importance of SAA in the 
dietary acid load caused protein, and more specifically protein sources high in SAA to be 
viewed as potentially promoting the gradual loss of bone mineral and development of 
osteoporosis over time (25). 
Frassetto et al. (45) developed prediction equations for NAE based on analysis of 
their own data in addition to meta analysis of available, sufficiently detailed reports, 
concluding that across 20 diets and 141 subjects, NAE increases one mEq for each additional 
0.91 g protein consumed on average, when holding potassium constant (r²=0.67): 
NAE = 0.91(Pro, g) 2 0.57(K, mEq) + 21  eq. 2 
The range of NAE occurring in the 20 diets studied by Frassetto was approximately 
15mEq/d to 115mEq/d. Accordingly, an increase of mixed protein intake from 60 to 100g/d, 
as described before, would be expected to increase the NAE by roughly 36.4 mEq/d, or over 
1/3 of the complete range of NAE encountered across from the low to high extremes of 
realistic diets. 
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The acid load of protein explains protein-induced urine calcium loss 
 A 1980 study in rats compared the effect of various protein sources on urine calcium, 
observing that the SAA or acidogenic fraction accounted for the effect (46). To verify, those 
authors fed sulfate independently of protein and observed increased urine calcium consistent 
with that induced by SAA. The following year two clinical studies reported that feeding 
isolated SAA increased urine calcium (47), and that the change in urine calcium with protein 
correlated with the change in NAE (48). Another trial in premature infants found urine 
calcium increased with the addition of cysteine to total parenteral nutrition solution (49). 
More recently it has been shown that a mineral water rich in sulfate increased urine calcium 
relative to milk, in spite of a similar calcium content (50). 
Recently, a meta analysis by Fenton (51) illustrated that across 25 clinical trials 
meeting selection criteria, 86% of the average change in urine calcium may be explained by 
the experimentally manipulated change in NAE: 
Urine Ca change, mmol = 0.28884+0.027118(NAE change, mEq)  eq. 3 
We performed a secondary analysis of the data summarized by Fenton (excluding two 
extreme values), testing whether the slope of urine calcium change regressed onto NAE 
differed between protein and non-protein sources of acid. We found no difference in the 
slope of protein vs. other acid sources (p=0.37), suggesting that the rise in urine calcium 
observed with increasing dietary protein can be completely explained by the dietary acid load 
of the protein. 
 Reinforcing this idea, we compared the value of urine calcium predicted from protein 
intake (using the meta analysis of Kerstetter, 50 mg/d with a 40g/d increase in protein, eq. 1) 
with that predicted from the combination of protein-induced increase in NAE and NAE-
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induced urine calcium (using eq. 2 from Frassetto and eq. 3 from Fenton, respectively). 
Again, for a realistic 40g increase in protein intake, the combination of eq.s 2 and 3 would 
predict an increase in NAE of 36.4 mEq and a corresponding increase in urine Ca of 55 mg, 
well within confidence limits of the 50 mg predicted by Kerstetter. Although the comparable 
outcomes of these analyses do not definitively rule out other mechanisms, they suggest that 
urine calcium loss in response to protein intake can be completely explained by the acid load 
of the protein. 
Mechanisms for Urine calcium Loss 
 The acid ash hypothesis posits that the well documented increase in urine calcium 
with additional dietary fixed acid or equivalent protein is the result of bone demineralization. 
However many studies have tested the possibility of a concomitant rise in intestinal calcium 
absorption, with discordant results. Additionally, newer research is beginning to cast light on 
plausible mechanisms for protein modified calcium handling in the kidney. 
Renal mechanisms 
 Increased protein intake reduces the reabsorption of calcium in the kidney (52-55), 
based on the difference between observed calcium excretion and that expected given 
glomerular filtration rate (GFR) and plasma calcium. An older microperfusion study in dogs 
found that experimentally induced acidosis led to reduced reabsorption of calcium in the 
distal tubule of the nephron (52). Correction of acidosis with supplemental base (NaHCO3) 
recovered calcium reabsorption. This was true in normal and parathyroidectomized animals, 
indicating the effect was independent of the PTH axis. A 2006 study in mice (56) found 
induced acidosis decreased expression of the calcium transporter TRPV5 in the distal tubule, 
and that acidosis did not modify urine calcium excretion in mice lacking the TRPV5 gene. A 
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subsequent study demonstrates in vitro that physiological acidosis impairs calcium uptake by 
TRPV5. Although the regulation of this gene is not completely understood, it is reasonable at 
this time to suspect that the acid load accompanying dietary protein, as evidenced by 
increasing NAE, reduces the amount and/or activity of this calcium reabsorbing gene in the 
distal nephron, causing extra calcium to be lost in the urine.  
 Several studies have also observed an increase in GFR in response to increased 
dietary protein (45; 57; 58), which also might account for additional calcium filtration and 
excretion. One randomized trial reported GFR was not increased by equivalent amounts of 
SAA (47). The mechanisms and implications of GFR in response to protein intake are not 
completely understood, but it is possible that some effect of protein on urine calcium exists 
independently of the protein acid load. It has also been recently proposed that the calcium 
sensing receptor CaR, which is involved in renal acid-base regulation (59) and calcium 
reabsorption (60), is regulated by aromatic amino acids (61) and may provide another link 
between protein intake and urinary calcium loss, independent of acid base status. However 
these mechanisms are not well understood, particularly in vivo.  
 Clinical investigations suggest higher protein intakes increase urine calcium by a 
similar amount irrespective of calcium intake (62). Jajoo et al. (63) observed a paradoxical 
increase in urine calcium with protein even in the face of increasing parathyroid hormone 
(that is, urine calcium increased when statistically holding PTH constant). This suggests 
protein causes an obligate calcium loss that is not simply a byproduct of other perturbations 
of calcium balance. If correct, this would suggest that urine calcium losses with protein may 
cause negative calcium balance unless compensated by increased calcium intake or 
absorption.  
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Although increased urine calcium has been associated with osteoporosis (64) and 
bone loss (19), the absence of predictable loss of bone mass with higher protein intakes (17) 
implies that calcium lost in the urine is otherwise recovered.  
Protein and Calcium Absorption 
Results are mixed on the clinical effect of protein on calcium absorption 
Over time several randomized studies have noted improvements in calcium 
absorption with higher protein intakes(57; 62; 65-67), however several other studies have 
seen no such effect (68-71). This discrepancy has been attributed to inadequacies in older 
methods of tracing calcium (8; 72) compared to modern dual stable isotope methods, though 
even this approach has not observed an effect in every study (71). A well controlled animal 
study by Bell et al. in 1975 (10) showed that excretion of radiolabeled 45Ca in the feces 
declined as its excretion rose in the urine in response to increasing protein intake. Net 
calcium balance was unaffected, except in rats consuming 10% energy from protein, which 
was concluded to be deficient for bone maintenance.  
Comparable observations were made in later rat studies (11; 12) and Whiting and 
Draper confirmed no benefit or harm to bone mass or composition after 10 months of a diet 
providing 35% energy as protein (soy and lactalbumin). A recent study by Gaffney-
Stromberg et al. (73) studied vesicles developed from the intestinal brush border mucosa of 
rats fed 5, 20 and 40% energy as protein, observing an increased Vmax, but no change in Km 
of calcium uptake. These changes explained a 14.4% improvement in calcium absorption in 
high vs. low protein animals, which more than compensated for protein induced urine losses.  
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Protein effects on calcium absorption may be independent of PTH and vitamin D 
Kerstetter et al. have demonstrated in humans that protein intakes below (42; 74; 75) 
0.9g/kg reduce calcium absorption, but elevate PTH and calcitriol, which normally increase 
calcium absorption. This counterintuitive result stresses that increases in absorption with 
protein intake are not likely to be mediated by canonical PTH and vitamin D pathways. 
Consistent with this, these same studies identified no changes in PTH or calcitriol between 
protein intakes of 1.0g/kg and 2.1g/kg, despite improvements in calcium absorption. 
Similarly, other randomized trials have not observed differences in calcitriol (48) or PTH 
(53; 62; 70) with higher compared to normal protein intakes. Conigrave (76) has shown in 
vitro that amino acid regulation of the calcium sensing receptor (CaR) suppresses the 
secretion of PTH from parathyroid cells. This would explain the results of Kerstetter, but it is 
not clear whether this mechanism has clinical relevance at high compared to normal intakes. 
Taken together, the presently available randomized trials suggest PTH is not involved 
beyond a threshold similar to the current RDA for protein. 
Geibel (77) reviews new knowledge that the CaR may also regulate calcium 
absorption in the intestine, potentially explaining the effect of dietary protein on calcium 
absorption. Dawson-Hughes et al. (78) did not directly measure absorption, but observe no 
changes in bone turnover in spite of increased urinary calcium in patients randomized to a 
five-fold increase in aromatic amino acids, the most potent regulating amino acids of the 
CaR, relative to a similar increase in branched chain amino acids. Those authors speculate 
that calcium absorption may have increased, since urine calcium losses did not appear to 
originate from bone resorption. 
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In contrast, we estimate using food composition tables that the aromatic, aliphatic and 
polar amino acids shown to most potently regulate the CaR (79) are present in similar or 
slightly higher amounts in soy compared to whey, casein and beef protein, and that aromatic 
amino acids alone are 20-40% higher in soy than these other proteins. If these amino acids 
are indeed responsible for clinically observed improvements in calcium absorption, it is 
curious that soy protein appears to not elevate absorption to the degree of other protein 
sources, if at all (42; 43). Note that this analysis does not account for digestibility or kinetics 
of amino acid absorption. 
Protein effects on absorption may be masked by alternate homeostatic mechanisms 
It is also possible that protein effects on absorption, including real effects of aromatic 
amino acids in soy, may be masked by other nutrients regulating the calcium balance. A 
recent study by Hunt et al. (62) observed that in subjects consuming 675 mg calcium daily, 
20% energy as protein increased urine calcium but also increased calcium absorption (29.5% 
vs. 26.0% at lower protein), such that net calcium balance was only slightly negative. In 
contrast, high protein did not alter calcium absorption in subjects consuming 1510 mg 
calcium daily (18.0%).  
These data might be explained by a consistent increase in calcium absorption induced 
by protein, combined with a linear decrease in calcium absorption fraction in response to 
total calcium intake as has been described previously (80). Specifically, if dietary calcium is 
sufficiently high to meet requirement, any additional absorption as a result of protein intake 
may be compensated by alternate homeostatic mechanisms. This paradigm would also 
account for the increase in PTH and calcitriol observed at low protein intakes (42; 74; 75), as 
alternate homeostatic mechanisms intervene to compensate for the lost efficiency of 
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absorption related to protein. Of course, these considerations are only speculative, and further 
understanding of the mechanisms of protein’s role in absorption is necessary. 
In spite of mixed results, it appears likely at this time that calcium absorption is 
indeed dependent on dietary protein, but that this effect may be masked in particular 
scenarios by interactions with other nutrients or by effects specific to protein source. 
Protein and Bone 
Bone cells are regulated by acid-base balance 
 In vitro work on the putative buffering of metabolic acid by bone tissue has verified 
that bicarbonate, phosphate, sodium and potassium on the bone surface can be exchanged for 
acid (30; 81; 82), which reasonably accounts for the acid gap described by Lemann (26; 27). 
In the last decade it has been increasingly appreciated that calcium efflux from bone in 
response to acid may not be a passive physiochemical process (83), but the result of 
physiological regulation of bone cells by acid base balance (4). Both osteoblasts and 
osteoclasts are responsive in vitro to changes in pH. The regulatory range is inverse but 
overlapping, such that at pH 6.9, osteoclasts are maximally active (84), but osteoblasts are 
strongly inhibited (85), whereas at pH 7.4, osteoclasts are ‘turned off’ and osteoblasts 
demonstrate high expression and activity of alkaline phosphatase (85). These changes appear 
to occur through well developed cell signaling cascades which are not fully understood, but 
include PGE2 stimulation of RANKL (86-88). These effects are potentiated by TNFα (89) 
and nuclear factor NFATc1 (90). Furthermore, H+ sensing receptors have been identified on 
the surface of osteoclasts (4). These novel pathways may also explain an older observation 
that acid moderates the influence of PTH on calcium efflux from bone in culture (91). 
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 The relevance of these pathways to the in vivo system is unclear. The intricacy of the 
emerging signaling cascade as well as the striking inverse correspondence between acid 
regulation of osteoclasts and osteoblasts imply these systems evolved to fill a defined 
physiological role. Arnett (4; 84) has described acid-base regulation of bone cells as a “fail-
safe” mechanism, ensuring that adequate buffer could be mobilized from bone to buffer an 
otherwise uncompensated acid load. This line of reasoning has been criticized (e.g., 22) on 
the grounds that a dietary acid load would hardly drive the pH of extracellular fluid below the 
well-buffered set-point of 7.4. Indeed, while an extreme dietary acid load can measurably 
depress the pH of the blood in animals (83; 92-94) and humans (95-97), a change greater 
than 0.014 on the pH scale was not observed in our review of the literature (96). 
 In spite of the small effect of diet acid load on blood pH, this effect may still be 
clinically meaningful. Arnett (84) notes that changes in pH on the order of 0.05 can double 
resorption pit formation. As previously mentioned, very small changes in net calcium flux 
from bone may contribute to gradual demineralization over decades, though it is clearly 
imprudent to extrapolate quantitative clinical estimates from studies in culture. Osteoclasts 
are reportedly most sensitive to pH changes near the middle of the sensitive range, around pH 
7.1 (84), which is not unrealistic for the layer of extracellular fluid bathing cells at the low 
end of the pH gradient in interstitial fluid, based on study in skin tissue (98). 
In rats, NH4+ loading causes an increase in serum ionized calcium, even in 
parathyroidectomized animals (99). This rise in serum calcium was blunted with 
pharmacological inhibition of cell mediated bone resorption (using colchicine or calcitonin), 
supporting the notion that bone matrix is actively degraded in response to an acid load. A 
randomized trial by Osther (100) also observed increasing serum ionized calcium in response 
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to acute acid loading. This effect has been reported in one trial of high protein (e.g., 22); 
however most studies have not seen a change in serum calcium with high protein intakes (53; 
66; 101). 
Effect of diet acid load on bone health 
 In animals, it has been reasonably consistent that feeding acid ash damages bone over 
time (93; 102; 103), though not in all studies (104). Barzel (105) reviewed that chronic 
NH4Cl supplementation in rats invokes a, “non-hormonal, slow but progressive and 
unrelenting mobilization of bone,” and that the end result is, “indistinguishable in all 
parameters measured from human osteoporosis.” Lemann (106) observed that NH4Cl 
administration in humans increases hydroxyproline, a marker of bone resorption, at a change 
in NAE that could reasonably be induced by a dietary acid load. A case study from 1982 
describes clinical improvement in osteomalacia secondary to chronic metabolic acidosis 
following administration of alkaline supplement. Similarly, a case series (107) reported 
clinically subnormal bone formation rate and bone mineral density in 10 patients with distal 
renal tubular acidosis. These bone abnormalities were corrected following one year of 
therapy with potassium citrate.  
 Epidemiology supports the notion that a high diet acid load negatively influences 
bone. The estimated net endogenous acid production (estimated NEAP) was developed by 
Frassetto et al. (38) to predict the change in NAE from the combination of protein and 
potassium intakes, with potassium serving as a surrogate for associated alkaline ash 
components in the diet. Another estimation of the diet acid load, the Potential Renal Acid 
Load (PRAL), was developed by Remer and Manz (1) using intakes of protein, phosphorus 
and negative coefficients (representing more alkaline contribution) for potassium, 
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magnesium and calcium (108). The estimated NEAP and PRAL are adversely correlated with 
bone density (109; 110) and broadband ultrasound attenuation (BUA) of the heel (111; 112), 
as well as bone turnover markers (109; 110), though not in all studies (113). 
 Both of these dietary acid load estimations include total protein intake. Two studies 
accounting for the diet acid load as well as the independent effect of protein within the same 
statistical model have observed an adverse effect of acid on bone mass that is opposed by a 
beneficial effect of total protein intake (19; 114). Corresponding to this evidence, Whiting 
and Draper (46) reported that feeding of SAA to rats induced osteopenia, while feeding of 
protein containing equivalent amounts of SAA had no such effect. In light of these 
observations, it seems that the total effect of protein on bone may conceivably be positive, 
neutral or negative, depending on the relative contribution of the protein to the diet acid load 
compared to an alternate, beneficial pathway. 
Effect of protein on bone density 
 High protein intakes have been shown to inversely predict bone mass in animal (115), 
epidemiological (116) and clinical (117) investigations; however positive associations have 
been much more frequently reported in cross sectional studies (118-124). Hannan (125) 
reported that lower protein intakes predicted bone loss longitudinally; however in this and 
some of the cross sectional investigations cited above, it is ambiguous whether benefits of 
additional protein correspond intrinsically to higher protein intakes, or to prevention of a 
protein deficiency. Cohort studies have not consistently observed a noticeable effect of 
protein intake on change in bone density over time (123; 126; 127), suggesting that if protein 
indeed causes the changes observed cross-sectionally, these benefits are likely to accrue very 
gradually over the lifespan. 
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 The division into animal and vegetable protein sources has been made as a crude 
index of the acid load of protein. Weikert (128) reports in a large sample (n=8,178) that while 
vegetable protein positively predicts BUA of the heel, animal protein is inversely associated. 
Similarly, Beasley (126) reports in young women that low intake of vegetable protein 
corresponds to lower bone density of the spine, while no association is observed for animal 
or total protein. In contrast, Promislow reports positive associations of bone density with 
animal protein, and negative associations with vegetable protein. 
 While it can generally be said that meat protein is higher in SAA than protein from 
plant sources, Massey (129) identifies that the variation in acid load within a food group can 
vary as much or more than variation between food groups. For example, egg protein provides 
79.6 mEq sulfate per 100g protein, chicken provides 65.0 and milk provides 54.8. For plant 
proteins, soy provides 39.8 while corn provides 61.4 and white rice provides 68.0. 
Additionally, cereals contain other nutrients which increase the dietary acid load (1) while 
vegetables are rich in organic bases (23). Animal / vegetable protein ratios may conflate the 
beneficial effects of a diet rich in vegetables in general with the effect of vegetable specific 
proteins, and also the effects of relatively low acid animal foods like milk with those of high 
acid proteins like pork. A high ratio may also represent an overall diet that does not contain 
adequate fruits and vegetables. Because of this potential bias, we discourage the use of 
animal / vegetable protein ratios in favor of investigation of more specific, individual food 
groups or nutrients. 
Possible interaction of protein with calcium intakes 
 Strong contradiction of the hypothesis that animal proteins are generally harmful 
comes from observations that dairy products improve bone accrual to a greater extent than 
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equivalent supplementation of calcium and vitamin D in growing children (130) and 
postmenopausal women (131). The possibility of a beneficial interaction of protein with 
calcium has been emphasized by Dawson-Hughes et al. (132). In a nested cohort 
investigation of 342 men and women randomized to calcium and vitamin D supplementation, 
they report increasing bone density over time among patients in the highest tertile of protein 
intake, but no such association in patients randomized to placebo. Vatanparast et al. (133) 
reported a positive correlation between protein intake and bone accrual over ~ 11.4 y in 
growing adolescents, and an augmentation of that benefit when calcium intake exceeded 1 
g/d.  
Protein intake and bone turnover 
 The effects of higher protein intakes on bone turnover markers are more equivocal. 
Allen et al. (70) reported no change in urine hydroxyproline, a product excreted in the urine 
in proportion to bone degradation, in response to formula diets containing 12 and 36 g 
nitrogen. Roughead also found no effect on bone metabolism markers in response to 12 vs. 
20% energy from protein, with meat accounting for the difference. Dawson-Hughes (78) also 
failed to show any effect of AAA compared to BCAA on turnover markers. 
 Hunt (62) reports a beneficial uncoupling of turnover given 20% vs. 10% energy as 
protein. Specifically, protein reduced deoxypyridinoline (a marker of bone degradation) 
without a concomitant decrease in bone specific alkaline phosphatase or osteocalcin (markers 
of osteoblast activity). In contrast, Kerstetter (134) found that relative to 0.7g/kg protein, 2.1 
g/kg increased N-telopeptide (another marker of bone degradation) and decreased bone 
specific alkaline phosphatase. Reddy (135) observed that a low carbohydrate, high protein 
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diet reduced osteocalcin without affecting N-telopeptide, bone specific alkaline phosphatase 
or deoxypyridinoline, suggesting possible harm to bone metabolism.  
 Several trials have reported markers of bone formation or resorption, but not both 
together, making them difficult to interpret. Bone turnover markers are normally well 
coupled, moving up or down in tandem (136), such that an increase in bone resorption is 
ambiguous unless bone formation is also known. That is, it cannot be determined whether 
bone formation increased to a greater degree than resorption, suggesting a net benefit to 
bone, or to a lesser degree, suggesting net harm to bone, or to a similar degree, suggesting 
bone turnover remains tightly coupled. 
It has been shown that increased turnover can predict risk of fracture even when 
formation and resorption remain tightly coupled (reviewed in 136); however it is not always 
so. Turnover is related to fracture risk along a J shaped curve (136), such that low and high 
levels may be detrimental. For example, within the present review, protein or energy 
deficiency cause a depression of both formation and resorption markers, which may remain 
well coupled (e.g.,137; 138). Despite decreased turnover, the long term impact of such 
deficiency is known to be harmful (22; 139-141). Conversely, increases in non-extreme 
exercise can elevate formation and resorption in tandem, yet produce improvements in bone 
health over time (e.g., 142; 143). Accordingly, the long term impact on bone health of a well-
coupled increase in turnover depends on the underlying cause of turnover changes. The long 
term consequence of protein induced turnover changes are not yet understood, and probably 
differ when comparing high to adequate vs. adequate to deficient intakes. 
 
 
19 
Protein intake and fracture 
 Fracture rates have been reported to increase (144-147) and decrease (139; 148; 149) 
with dietary protein. Available studies have generally been limited by a small number of 
incident fractures. One of the largest available studies (n=85,900 women over 12 y) observed 
no effect of protein on hip fracture, but even this tremendous sample size yielded only 234 
incident hip fractures. The same study did observe a linear increase in wrist fracture with 
protein intake, with a 22% increase in risk at intakes > 95g/d compared to <68g/d. This effect 
was attributable to animal, and not vegetable protein, consistent with the acid-ash hypothesis. 
Darling (17) summarized the available data for hip fracture, finding no effect of protein 
intake in a meta-analysis weighted by sample size. This was true for total, animal and 
vegetable protein, however only 3 studies were included in each analysis.  
 Heaney and Rafferty have recently discussed the standard of “preponderance of 
evidence” in drawing conclusions from conflicting reports (150). They illustrate that because 
most studies are not sufficiently powered to reduce the type II error risk (failing to reject a 
null hypothesis that is false) to the same level as the 5% standard for type I error risk, any 
one study is more likely to incorrectly report no effect than to incorrectly declare statistically 
significant results. In this context, they advise that a mixture of positive and null study results 
be cautiously interpreted as evidence for a probable true effect. Aggregate data for urine 
calcium, calcium absorption and bone density are amenable to this standard, as studies have 
found significant effects in a consistent direction as often or more often than not. However 
data for bone turnover and fracture rates in response to protein intakes are more puzzling, 
since both positive and negative results have been reported as frequently as has no 
association.  
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A Dual-Pathways Model of Protein and Bone Health 
 It is curious that fracture rates may be influenced in both directions. As discussed by 
Darling et al. (17), publication bias may cause a polarization of available literature on these 
outcomes, causing significant findings in both directions to be over-reported with respect to 
null results. Alternatively, as introduced previously, we (19) and others (21; 151; 152) have 
supported a competing pathway model, in which dietary protein may cause an increase or 
decrease in bone health, depending on the availability of calcium and alkali ash in the diet. 
The cause of purported negative effects is clear as delineated by the acid-ash hypothesis. The 
pathway for positive effect may be mediated by increases in calcium absorption above 
urinary losses. IGF-1 has also been proposed as a mediator of beneficial influences of 
protein. 
Insulin-like growth factor 1 
 Insulin-like growth factor 1 (IGF-1) has been shown to hold predictive value in 
osteoporosis in older individuals (153) and in bone accrual in young males (154). It has been 
linked to multiple pathways in bone cell regulation, and administration of IGF-1 ex vivo 
stimulates a general increase in bone growth (155). Dietary protein is known to modify both 
IGF-1 and some of its binding proteins (156); it has therefore been an attractive candidate as 
a mediator of protein’s influence on bone (22; 151; 157; 158). 
 Schurch et al. (159) showed that supplementation of protein reduced bone loss in the 
femur in patients with recent hip fracture. These benefits were accompanied by and attributed 
to simultaneous increases in circulating IGF-1. This group reported recently (160) a similar 
response to protein supplementation in a comparable population, with measurable increases 
in IGF-1 within 7 days of initial supplementation. These changes, if generalizable, could 
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certainly explain benefits of protein to bone health. These patients were initially somewhat 
protein deficient, however, and the notion that IGF-1 can be elevated by increasing protein 
beyond the threshold of adequate intake levels is not uniformly supported (161; 162).  
 Three randomized trials to implicate protein intakes above the RDA as relevant to 
IGF-1 regulation. Ballard (163) randomized young adults to 70 g supplemental carbohydrate 
or 42 g supplemental protein plus 28 g carbohydrate during an exercise intervention. The 
additional protein was observed to increase IGF-1, though protein intake appeared adequate 
in both groups. The previously reviewed study of protein intake at low and high calcium 
intakes by Hunt (62) discovered improved IGF-1 with protein, independently of calcium 
intake. Two studies by Dawson-Hughes et al. (14; 78) shed additional light. The first shows 
increased IGF-1 and decrease in a bone resorption marker with 1.6 in lieu of 0.8 g/kg protein. 
The second shows an increase in IGF-1 following a large increase in isolated aromatic amino 
acids, while no such increase is observed with branched chain amino acid supplementation. 
 IGF-1 may also link protein nutrition to muscle mass (156). It has been proposed 
elsewhere (164) that documented increases in lean body mass in response to the dietary 
protein level (165; 166) may connect protein intake and bone health. Increased mechanical 
loading of bone by an increased muscle mass would be expected to promote bone mass and 
strength (167).  
Alternative suppression of the diet acid load 
 An almost overwhelming amount of support exists for the notion that increasing 
sources of alkali ash in the diet is beneficial to bone (63; 168-174). The primary difficulty in 
the epidemiology in this area has been attributing benefits specifically to suppression of the 
dietary acid load, as opposed to the additive or interactive influence of the many nutrients 
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provided by enrichment of fruits and vegetables in the diet. Zerwekh (115) illustrated in rats 
the ability of supplemental base, potassium citrate, to ameliorate the osteomalacia induced by 
a high casein diet, while KCl had no such effect. Additionally, a remarkable number of 
randomized trials of supplemental sources of base have fortified this concept over the past 
few years, relying mostly on bone turnover markers for shorter term inference about bone 
metabolism. 
 Comparisons of salts of sodium and / or potassium with bicarbonate, citrate and / or 
chloride indicate that supplemental base, not potassium or other components, favorably 
uncouples turnover, suppressing resorption without reducing formation (35; 36; 175; 176). 
This effect is also achieved with alkaline, compared to relatively more acidogenic mineral 
water (177). Furthermore, a longer term study demonstrated that potassium citrate, and not 
potassium chloride, improves bone density of the lumbar spine, femoral neck and total hip 
(178).  
Taken together, the epidemiology of fruits and vegetables and clinical investigations 
of supplemental base offer solid documentation that positive changes to bone health are 
achievable through a diet rich in fruits and vegetables, with essentially no risk, but rather 
many additional health benefits (23). 
Methodological Issues 
Accounting for simultaneous, opposing effects of protein and the diet acid load 
 In light of the evidence reviewed herein, we propose that experiments or statistical 
models that fail to account for both proposed positive and proposed negative effects of 
protein may fail to observe real effects in both directions. Where positive and negative 
effects arise from the same independent variable, the total effect will be biased toward zero 
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unless mediators of opposing effects are accounted for (179). In epidemiological study, 
opposing effects may be investigated using meditational or path analysis (180). For example, 
the effect of total protein on bone health may be modeled with and without adjustment for 
sulfur amino acids and/or IGF-1. The change in the main effect of protein before and after 
adjustment represents the portion of protein’s influence that is attributable to the mediating 
factor (180). In experiments, appropriate controls should be incorporated to isolate 
potentially conflicting effects. 
Estimation of the diet acid load in bone studies 
 Fenton et al. (181) performed a meta-analysis of the influence of phosphate intake on 
calcium balance, finding no net effect across 12 studies of acceptable methodological quality. 
Those authors argue this result refutes the acid ash hypothesis, since phosphate is included in 
those dietary components though to influence NAE (1). It has been known for many years, 
however, that the role of phosphorus in calcium balance is more complex than predicted 
based only on its role in the diet acid load (182; 183). In 1981 Linkswiler (184) reviewed 
consistent evidence that phosphorus intake depressed urine calcium loss. Heaney et al. have 
since repeatedly shown (185-187) that phosphorus also increases fecal calcium loss, 
specifically endogenous calcium loss through secretions into the intestine, such that any gain 
at the kidney is lost in the intestine.  
These unique effects of phosphorus are not observed with other dietary acid ash 
components, and may have an opposite or no effect on bone in spite of its role in predicting 
NAE. This does not refute the negative role of an acidic diet in bone health, but rather calls 
into question the utility of NAE prediction equations that include phosphorus or other 
nutrients with multiple influences on bone. In a cross sectional study of postmenopausal 
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women (19) we observed a negative influence of diet acid load from SAA on bone density of 
the spine after adjusting for total dietary protein. We observed no similar association with the 
NEAP or PRAL, which would theoretically also represent the diet acid load. The PRAL (1) 
accurately predicts change in NAE induced by diet, but includes phosphorus, magnesium, 
calcium and total protein in its estimation. Each of these nutrients appears to have unique, 
non-acid related roles in bone health (168; 169; 188; 189). Similarly, estimated NEAP (38) 
accurately predicts NAE, but does not account for possible positive roles of protein 
independently of the acid load from dietary protein (44). For general prediction of NAE, 
these equations are superior to the use of SAA alone; however, when the effect of the diet 
acid load on bone health is specifically investigated, it seems prudent to test individual, rather 
than aggregate effects of SAA, total protein, potassium (as a surrogate for organic base) and 
minerals which may influence bone health through alternate pathways. 
Discerning high from non-deficient protein intakes 
The importance of dose cannot be overemphasized in this research. In many trials, it 
has been ambiguous whether purported protein effects are due to benefits of higher protein 
intakes, or due to correction of a frank protein deficiency. In future trials, it would be very 
helpful to compare 3, rather than 2 levels of intake where possible: one level that is 
marginally deficient, one level sufficiently high as to preclude frank deficiency and one that 
is higher to explore the impact of protein above adequate levels. For example, the intakes 
0.7g/kg, 1.0g/kg and 2.1g/kg have been used by Kerstetter (57; 75; 134), and have resulted in 
more decisive interpretation. Where 3 parallel arms are not feasible, care should be taken to 
unambiguously compare high to adequate, or adequate to deficient protein intakes, as the 
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comparison between high and deficient intakes is not useful in evaluating the possibility of 
harm of higher protein intakes to bone.  
Similarly, in epidemiological studies, it would be preferable to compare subgroups of 
the population divided according to comparable ‘adequate’ and ‘high’ thresholds, rather than 
comparing tertiles within a population that may be generally protein deficient. For clarity of 
interpretation, protein intakes should be reported as both absolute gram quantities and as 
intakes normalized to body size (e.g., g/kg body weight), as reporting only % energy as 
protein leaves the sufficiency of protein intake uncertain. 
Measuring and reporting bone turnover 
Where turnover markers are reported, bone formation and degradation markers 
should always be reported in tandem. Several forms of reporting an “uncoupling index” have 
been described (e.g.,190) and are helpful in evaluating the likely net effect of changes in 
turnover to bone health. We recommend reporting uncoupling as the ratio of percent change 
from baseline for formation and resorption markers: 
( ) ( )
resorptionbaseline
resorptionbaselineresorptionend
formationbaseline
formationbaselineformationendRatioUncoupling −−=
     eq. 4 
 
A value > 1 would suggest net formation. The ratio of percent change is likely to best 
account for the high degree of inter-individual variation in turnover markers. 
The use of ratios in prediction equations 
 Ratios of nutrients have often been reported where nutrient interactions are thought to 
exist, for example, between animal and vegetable protein or between protein and calcium. 
Statisticians have warned for decades of the problems of including ratios in statistical 
prediction equations (191-193), including difficulties in interpretation, violation of  
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distribution assumptions, spurious associations between ratios with the same denominator 
and inaccuracy in individual variable coefficients (although the predictive accuracy of the 
complete model is not affected). Although it may be appropriate to compare calculated ratios 
across groups (for example, the uncoupling ratio described above was greater in population A 
than in population B), it is generally preferable to form prediction equations using main 
effects and an interaction term. A model including interactions should always include 
corresponding main effects, unless compelling theoretical reasons exist for excluding them 
(194). For example, applying such a model for the possible interaction of protein and 
calcium: 
BMD = B0 + B1(protein) + B2(calcium) + B3(protein*calcium)  eq. 5 
This model avoids the disadvantages outlined above, but still provides all the information 
afforded by a ratio and is more easily interpreted. See (194) for a non-technical discussion of 
dealing with interaction in regression. 
Conclusions 
Our review finds ample evidence that dietary protein may hold both positive and 
negative effects on bone. In many scenarios, these opposing effects may cancel one another 
out, explaining the lack of a result in the meta analysis by Darling (17). It is feasible, though 
requires additional study, that the combination of moderate increases in protein intake with 
ample dietary calcium, alkalizing nutrients such as fruits and vegetables or alkaline mineral 
waters may uncouple positive and negative effects. This may permit the benefits of dietary 
protein to bone to be enjoyed without contradictory adverse effects. 
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Chapter 3 
A positive association of dietary protein with lumbar spine bone mineral density 
is suppressed by a negative association of protein sulfur 
 
Abstract  
Dietary protein is theorized to hold both anabolic effects on bone and demineralizing 
effects mediated by the diet acid load of sulfate derived from methionine and cysteine. The 
relative importance of these effects is unknown but relevant to osteoporosis prevention. Post-
menopausal women (n=161, mean±SD 67.9±6.0 y) were assessed for areal bone mineral 
density (aBMD) of lumbar spine (LS) and total hip (TH) using dual X-ray absorptiometry, 
and dietary intakes of protein, sulfur-containing amino acids and minerals using a USDA 
multiple-pass 24 h recall. The acidifying influence of the diet was estimated using the ratio of 
protein / potassium intake, the potential renal acid load (PRAL) and intake of sulfate 
equivalents from protein. aBMD was regressed onto protein intake, then protein controlled 
for estimated dietary acid load. A step-down procedure assessed potential confounding 
influences (weight, age, physical activity and calcium and vitamin D intakes). Protein alone 
did not predict LS aBMD (P=0.81); however, after accounting for a negative effect of sulfate 
(ß=-0.28, P<0.01), the direct effect of protein intake was positive (ß=0.22, P=0.04). At the 
TH protein intake predicted aBMD (ß=0.18, P=0.03), but R² did not improve with 
adjustment for sulfate (P=0.83). PRAL and the protein / potassium ratio were not significant 
predictors of aBMD. Results suggest that protein intake is positively associated with aBMD, 
but benefit at the LS is offset by a negative impact of the protein sulfur acid load. If validated 
experimentally, these findings harmonize conflicting theories on the role of dietary protein in 
bone health.
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Introduction 
Recent literature reflects discordant views on the role of dietary protein in bone health 
(1). Protein appears to hold an anabolic influence on bone, mediated by bone-active 
hormones, particularly insulin-like growth factor-1 (1), and may increase calcium absorption 
(2). Conversely sulfate equivalents derived from methionine and cysteine metabolism are 
exchanged in the kidney for acid equivalents (3); such a dietary acid load has been 
demonstrated to cause bone demineralization in animals (4;5) and is associated with reduced 
bone mineral mass in humans (6;7).  
It has been proposed that bone demineralization is promoted by a mild but chronic 
dietary acid load characteristic of the Western diet (7). This acid load can be characterized by 
nutrient intake as the estimated net endogenous acid production (NEAP), calculated using a 
ratio of protein to potassium intake (8;9), or using a function of protein, calcium, potassium, 
magnesium and phosphorus intake known as the potential renal acid load (PRAL) (3;10). 
These methods assume the sulfur content of protein is a fixed ratio; however, it is 
acknowledged that the estimation of actual sulfur intakes improves estimations of dietary 
acid load (11;12), as actual methionine and cysteine contents vary according to protein 
source. Currently nutrient databases are available which account for variation in sulfur-
containing amino acids (13).  
The primary aim of this study was to elucidate the role of dietary protein in bone 
health status as estimated by dual X-ray absorptiometry (DXA) measures of areal bone 
mineral density (aBMD). Diet record analysis was used to estimate intakes of total protein 
and sulfate from amino acids for calculation of the dietary acid load. We anticipated that 
although dietary protein would be positively related to aBMD, this relationship would be 
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suppressed by a negative association of aBMD with the dietary acid load related to protein 
intake. 
Methods 
Participants 
Our sample consisted of 161 post-menopausal women (mean±SD 67.9±6.0 y) from 
Champaign County, IL participating in an ongoing study of the relation between physical 
activity, gait ability and self-efficacy. Subjects were recruited using local media advertising, 
churches, senior centers and health facilities. Women with neurological illness or severe 
orthopedic or cognitive limitations preventing physical testing for the broader study were 
excluded. Cross-sectional data were used for the present analysis. Study participants 
provided written, informed consent; all study procedures met ethical standards of and were 
approved by the Institutional Review Board of the University of Illinois at Urbana-
Champaign. 
Dual x-ray absorptiometry 
For bone measures, women changed into medical “scrubs” or wore light-weight 
clothing and removed all jewelry and other clothing except underwear. Lumbar spine (LS) 
and total hip (TH) aBMD were measured by DXA using a Hologic QDR 4500A bone 
densitometer (software version 11.2, Bedford, Massachusetts). LS scans included lumbar 
vertebrae L1-L4. Short and long-term accuracy of the densitometer were verified by scanning 
a manufacturer’s hydroxyapatite spine phantom of a known density. All DXA scans were 
performed by an Illinois state licensed x-ray technologist and analyzed by the same 
investigator trained in scan analysis by Hologic, Inc. (EM Evans). Precision for DXA BMD 
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measures of interest are 1 – 1.5% in our laboratory with CV% calculated from duplicate 
scans of both young adults and postmenopausal women. 
Dietary intake and estimation of acid load 
Intake was assessed using the USDA multiple-pass 24 h dietary recall method 
(14;15). Participants completed an interview with researchers to screen for missed foods, 
portion size clarification, and recall completeness. Diet records were analyzed for total 
energy, protein, methionine, cystine and micronutrients of interest for calculation estimated 
NEAP: potassium, calcium, magnesium and phosphorus. Nutrient analysis was performed 
using Nutritionist Pro version 2.3.1 (First Data Bank, San Bruno, CA).  
Protein sulfur load was calculated as mEq/d using intakes of methionine and cystine 
divided by their molecular weights, as described by Frassetto et al. (8). 
⎟⎠
⎞⎜⎝
⎛ ⋅+⋅=
3.240
)(2
2.149
)(2)( mgcystinemgmethioninemEqSulfur  eq. 1 
The PRAL of the diet was estimated according to the method of Remer, Dimitriou 
and Manz (3; 10): 
PRAL = 0.49 protein(g)+0.037 ⋅ /P(mg)-0.021⋅ ⋅K(mg)-0.02 ⋅Mg(mg)-0.013 ⋅Ca(mg)       eq. 2 
The protein / potassium ratio estimation of NEAP was calculated according to the method of 
Frasetto et al. (8): 
2.10
)/(
)/(5.54 −⋅=
dmgpotassium
dgproteinNEAP  eq. 3 
Statistical analyses 
Distributions were assessed for normality and outliers using the Shapiro-Wilk statistic 
in conjunction with box plot outlier labeling (16). Correlations for energy intake, protein, 
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protein sulfur, minerals of interest, vitamin D, aBMD and body composition (weight, fat 
mass and lean mass) were calculated for descriptive purposes. 
Statistical tests followed the prescriptions of MacKinnon, Krull and Lockwood (17) 
for modeling suppression and mediation effects. Mediation effects, more commonly 
described as intermediate endpoints in epidemiology, describe a situation where all or part of 
the influence of X on Y is transmitted through a third, intermediate variable. Modeling these 
effects is similar statistically, but different conceptually from confounding variables, in 
which a spurious association between two variables is explained by a third, non-intermediate 
variable which presumably causes both X and Y. A suppressor effect is a special case of an 
intermediate endpoint in which X has a direct association with Y and an indirect association, 
transmitted through a third variable, which is opposite in sign to the direct effect (17). For 
example, our present hypothesis posits that protein intake will be positively associated with 
aBMD (the direct effect), but that a third, intermediate variable, the acid load associated with 
protein intake, will be negatively associated with aBMD, thereby suppressing the association 
of protein intake with aBMD unless the model is statistically controlled for the intermediate 
variable. 
Sulfate, PRAL and the protein / potassium calculation were entered individually as 
the second block of a regression equation containing dietary protein to predict aBMD of the 
LS and TH.  The change in R² was observed between first and second blocks, indicating the 
improvement in the model conferred by the inclusion of respective estimates of diet acid 
load. A step-down regression procedure was then applied to examine the potentially 
confounding influences of body weight, age, physical activity and calcium as well as vitamin 
D intakes. Because the interaction of dietary protein and calcium intakes have been reported 
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to impact bone health (1; 18), a protein by calcium interaction term was also tested for 
statistical control. At each step, covariates yielding a P value >0.1 were removed from the 
model. Covariates were tested before and after the addition of sulfate to the model to 
ascertain any confounding influences. The variance inflation factor was observed as a test of 
multicollinearity.  
Where change in R² was significant, unique protein effects and sulfur-mediated 
protein effects were estimated and tested for significance. The “Indirect” mediation macro 
for SPSS by Preacher and Hayes (19) provided bootstrapped variance estimates for the 
indirect or sulfur-mediated effect using 10,000 resamples with replacement. To describe the 
individual contributions of protein and related sulfur intakes, scatter plots and least squares 
regression lines were produced using sample Z-scores (difference between observation and 
sample mean divided by SD) of aBMD and protein adjusted for sulfur, then of aBMD and 
sulfur, adjusted for protein (Figure 1). Additionally mean LS aBMD was compared for 
subjects split across the median for both total protein and sulfur from protein (Figure 2). 
SPSS 14.0 was used in all analysis.  
Results 
Among participants, 128 (80%) were taking supplemental calcium (defined as a daily 
supplement containing at least 100 mg calcium), 34 (20%) were taking a prescribed 
osteoporosis medication, 50 (31%) were taking hormone replacement therapy and an 
additional 64 (40%) had taken hormone replacement therapy in the past. One participant 
completed the LS scan, but not the TH scan, reducing the sample size for TH tests to 160. 
Parametric and robust descriptive statistics are presented in Table 1. Spearman’s correlations 
of aBMD with protein, energy and estimates of the diet acid load are presented in Table 2. 
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Protein, sulfur, PRAL, and the protein / potassium index of NEAP were positively correlated 
with one another (all P<0.01), but of the dietary variables only sulfur exhibited a significant, 
negative correlation with LS aBMD. 
At the lumbar spine, the step-down procedure eliminated, in order, vitamin D 
(P=0.83), calcium x protein interaction (P=0.77), energy/wk expended in physical activity 
(P=0.55), age (P=0.63) and calcium (P=0.10), leaving only weight as a covariate in the final 
model (P<0.01). In the first block, protein held no association with LS aBMD (P=0.81). 
Neither the addition of PRAL (P=0.66) nor estimated NEAP using the protein / potassium 
ratio (P=0.97) significantly improved the model fit; however, adding sulfate demonstrated a 
negative association of sulfur from amino acids with LS aBMD, and a positive association of 
protein with LS aBMD (Table 3). 
The standardized coefficient for sulfate regressed onto protein intake was 0.69 
(P<0.01). The standardized indirect coefficient of protein, or that portion of protein’s total 
predictive influence that is mediated by its sulfur content, was -0.19 (95% CI, -0.35, -0.04), 
opposite in sign and similar in magnitude to the estimated ß for sulfur-controlled protein, 
0.21 (Table 3). Despite correlations between protein and acid-load estimators, the largest 
Variance Inflation Factor observed was 1.9 (for protein and sulfur), well below the 
recommended threshold of 10 for detecting problematic multicollinearity (20). The 
relationships of LS aBMD with protein and LS aBMD with sulfur were linear within the 
range of reported protein and sulfur intakes (Figure 1). 
At the total hip, step-down regression removed energy expended in physical activity 
weekly (P=0.95) vitamin D (P=0.33) and the calcium · protein interaction (P=0.26) terms, 
but retained age (P<0.01), weight (P<0.01) and calcium intake (P=0.02) as covariates. 
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Protein was a significant (P=0.03), positive (ß=0.18) predictor of TH aBMD; however, no 
improvement in R² was observed with the addition of PRAL (P=0.87), estimated NEAP 
using the protein / potassium ratio (P=0.29) or sulfate (P=0.83) to the model. The largest 
Variance Inflation Factor observed was 2.1. 
Discussion  
Our findings suggest that, within the range of intake reported in our sample, 
increasing dietary protein is beneficial to aBMD of the lumbar spine and total hip of 
postmenopausal women, but that this benefit is suppressed at the lumbar spine by the dietary 
acid load associated with sulfur containing amino acids. Neither the PRAL nor estimated 
NEAP using the protein / potassium ratio contributed to the prediction of aBMD at either 
site. The observed regression coefficients are small but clinically meaningful. A participant 
consuming mean levels of sulfate, but protein at +1 SD would be predicted to have 3.2% 
(95% CI: 0.12 to 6.4) additional LS aBMD above the sample mean. Conversely a subject 
consuming mean protein but +1 SD sulfate would be predicted to have 4.3% (-7.4 to -1.2) 
lower LS aBMD. Although further research is necessary to validate these cross-sectional 
data, the observed differences support hypotheses that improving intake of low-sulfate 
protein sources, or alternatively improving protein intake with a corresponding reduction in 
the dietary acid load may be beneficial in osteoporosis prevention. 
Protein deficiency is detrimental to bone health (21). Observational studies of bone 
health tend to promote a positive view of protein intakes above 0.8 g.kg-1.d-1 (22-26), though 
not all studies are favorable (27-29). It has long been established that increasing protein 
intake elevates calcium losses in urine; in many studies fecal calcium measures indicated no 
apparent compensation in calcium absorption, promoting the view that urinary calcium must 
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reflect mineral lost from bone (30). More recently, however, Kerstetter et al. (2) have 
demonstrated not only increased calcium absorption, but a reduction in urinary calcium of 
bone origin in subjects consuming 2.1 g.kg-1.d-1 protein compared to 1.0 g.kg-1.d-1 in a kinetic 
study using dual stable calcium isotopes. In the same study, no net difference in bone mineral 
mass were observed between levels of protein intake, however there was a trend toward 
reduced bone turnover.  
In light of the influence of protein on urinary calcium excretion, Dawson-Hughes (1; 
31) suggests that increased protein intake is beneficial provided that calcium intake is 
sufficient to support bone growth and urinary losses. Skov et al. (32) and unpublished data in 
our lab (in review) demonstrate benefits of protein above current recommended levels to 
bone mineral mass, in the presence of adequate calcium, during weight loss. In the present 
study the interaction of calcium and protein intake was not significant. 
Proposed mechanisms whereby dietary protein may enhance bone health include 
providing substrate for collagen deposition and increasing circulating levels of insulin-like 
growth factor-1, a known growth factor for bone (1). A recent prospective study by Alexy et 
al. (33) demonstrated improved bone health in youth with increasing protein intake. 
Conversely, bone status was negatively associated with the diet acid load, estimated by the 
PRAL, which includes estimation of the acidifying effect of dietary protein. The authors 
noted that this index of dietary acid load does not directly assess methionine and cysteine 
content of individual proteins, but assumes a fixed proportion of sulfur to protein. The young, 
growing population is distinct in several important ways from the older population of the 
present study, but the results illustrate a similar concept: protein is positively associated with 
bone mineral mass, but also contributes to an acid load with negative ramifications for bone. 
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Total protein and protein sulfur are highly and intuitively correlated, but the actual 
ratio depends on protein source. Methionine is an essential amino acid, and deficiency causes 
adverse health outcomes. However, our results suggest that the addition of lower sulfate 
protein to a diet that is already adequate in all essential amino acids may be beneficial in 
osteoporosis prevention; further research is necessary to test this hypothesis. Soy is 
implicated as a protein source with a low sulfur to protein ratio (13), estimated by Massey 
(34) at 39.8 mEq sulfur / 100 g protein, compared to a mid-range 54.8 mEq / 100 g protein 
for milk and 59.4 mEq / 100 g protein for beef, and a higher 73.0 mEq / 100 g protein for 
pork and 82.2 mEq / 100 g protein for oatmeal. Experiments have tested the impact of soy 
protein, with and without isoflavones, on calcium balance with mixed results (35-38). 
Alternatively increased protein from all sources in connection with enhanced intake of 
alkalizing nutrients may be beneficial. It has been shown that a more alkaline diet is 
associated with improved bone density (39-43), and that supplementation of potassium 
bicarbonate or potassium citrate attenuates bone turnover (44;45). Jajoo et al. (46) 
demonstrated that replacing some cereal, an acidifying diet component, with more base-
producing fruits and vegetables resulted in reduced levels of parathyroid hormone, bone 
resorption and calcium excretion relative to controls. 
It is conceptually important that the positive association in this sample between 
protein and LS aBMD, controlling for sulfur, was almost perfectly negated by the negative 
association of sulfate equivalents from methionine and cysteine and aBMD. This suppressor 
effect indicates that any study evaluating the association between protein intake and bone 
mineral status without controlling for actual sulfur content of protein may observe no 
significant correlation, despite real positive and negative protein effects. A neutral combined 
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influence of protein and sulfur on aBMD prediction would mask true effects in both studies 
hypothesizing detrimental acid load effects to bone, and studies hypothesizing beneficial 
effects of dietary protein. This suppressor effect might explain the discordance of reports 
concerning the impact of dietary protein or acid load on bone health. Likewise it is possible 
that uncontrolled influences of the total dietary acid load might explain conflicting reports. If 
true, this would suggest that future studies of associations between protein intake and bone 
density must account for the dietary acid load in order to produce unbiased results. 
Our results suggest that direct estimation of sulfur from amino acids may perform  
better than the protein / potassium ratio or PRAL in studies of acid-base balance and bone 
mineral mass. These constructs were developed and validated for the estimation of the 
acidifying influence of dietary intake (3; 8-10). However because each estimates the 
acidifying effect of protein as a fixed ratio of total protein intake, they may not be well suited 
to the investigation of bone, where the negative acid effect seems to be opposed by an 
anabolic protein effect. Indeed our results suggest that the negative and positive effects of 
protein may neatly cancel one another out at the LS, leaving the estimated influence on bone 
of total protein, as used in the protein / potassium ratio and PRAL, neutral in spite of 
otherwise reliable estimations of dietary acid load. The PRAL is also a function of calcium 
and phosphorus intake, which have well established influences on the calcium economy (47). 
These factors may further confound the influence of the PRAL on bone. In light of these 
complex associations, it may be advisable to use direct intakes of protein, amino-acid sulfur 
(the acidifying agent of protein), and other relevant minerals such as potassium in lieu of 
estimated NEAP when calcium balance or bone mineral mass are investigated. 
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It is not clear why this suppressive association of sulfur intake would describe aBMD 
at the lumbar spine and not at the total hip, although differences in the response of these two 
sites are commonly reported (48-50). The change in R² at the LS indicated a small likelihood 
of a type I error, or inappropriate rejection of the null hypothesis that sulfur intake does not 
predict aBMD. Conversely, a post-hoc power analysis of the regression at the hip was 
performed, and indicated a power of 0.74 to detect an improvement in R² as large as that 
observed at the spine. Though it is not entirely improbable that our regression failed to detect 
a true difference at the hip, it is very possible that a real difference between protein 
associations at the hip and spine explain divergent findings. Differences in observations 
between these measurement sites may relate to differing levels of trabecular compared to 
cortical bone content; specifically, the ratio of trabecular to cortical bone is greater at the 
spine than at the hip. It has been theorized that trabecular bone, being more metabolically 
active, may be more sensitive to dietary intervention, at least in the short term (51;52). 
However a post-hoc analysis of the trochanter sub region, with a greater proportion of 
trabecular bone, did not mimic the findings at the LS in this sample (data not shown).  
Alternatively it is possible that the weight-bearing load at the hip during ambulation may 
blunt the effects of dietary factors.  
This study is not without limitations; the constraints of cross-sectional data are 
recognized. This research is performed in the context of a broader body of literature 
suggesting causal connections between protein intake and bone mineral mass (31;32), sulfate 
intake and acid-base balance (53;54) and acid base balance and bone demineralization 
(4;5;6;44;55). The results are theoretically consistent and harmonize apparently conflicting 
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research; however, this observational study offers no basis for new causal inference and is 
best interpreted as a rationale for additional investigation. 
In conclusion, protein intake is positively associated with aBMD in postmenopausal 
women, but this association is suppressed by a negative association of sulfur from amino 
acids at the lumbar spine. This observation may reconcile reports of positive impacts of 
dietary protein on bone health with reports of a negative impact of the acid load from sulfur-
containing amino acids. At the total hip dietary protein intake is positively associated with 
aBMD, and may not exhibit the same negative association with sulfur from protein as 
observed at the spine. These results highlight the need to evaluate actual sulfur contents of 
varying dietary protein sources rather than assuming a fixed ratio of sulfur to protein. Future 
research in this line of inquiry should evaluate the role of dietary protein in preserving bone 
health in populations at higher risk for fracture such as the elderly. 
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Table 3.1. Descriptive statistics, 161 postmenopausal women. 
 Mean SD Median IQR1 
Age, y 68 6.0 66 63 – 72 
Weight, kg 73.1 15.1 70.7 62.7 – 80.7 
BMI, kg/m² 28.2 5.3 27.7 24.4 – 31.4 
kJ/d 7063 2335 6749 5402 - 8548 
Protein, g/d 74.7 25.0 76.9 54.7 - 88.9 
calcium, mg/d 840 34.5 781 513 - 1079 
Vitamin D, mg/d 3.36 2.73 2.85 1.08 - 4.90 
PRAL2, mEq/d 2.4 16.6 1.9 -9.9 - 13.3 
Est. NEAP3 49.2 22.2 45.0 35.2 - 57.6 
Protein Sulfur4, mEq/d 28.4 15.6 27.4 17.3 – 38.6 
LS aBMD5, g/cm2 0.99 0.15 0.98 0.88 - 1.08 
TH aBMD, g/cm2 0.88 0.13 0.87 0.78 - 0.97 
1 Inter-quartile range. 2 Potential Renal Acid Load (3,10), calculated according to formula 2. 3 
Estimated Net Endogenous Acid Production (8), calculated using the ratio of protein to 
potassium intake, according to formula 3. 4 Sulfur content of reported dietary protein sources, 
calculated according to formula 1. 5 Areal Bone Mineral Density.
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Table 3.2. Correlations of dietary intakes, diet acid load estimations and areal bone mineral 
density (aBMD) of the lumbar spine (LS) and total hip (TH) in postmenopausal women. 
  Protein Energy PRAL1 NEAP2 Sulfur K+ LS BMD 
Energy, kJ 0.59       
 P <0.01        
PRAL1 0.43 0.05      
 P <0.01 0.56       
Est. NEAP2 0.41 0.02 0.88     
 P <0.01 0.82 <0.01      
Sulfur3 0.67 0.33 0.33 0.27    
 P <0.01 <0.01 <0.01 0.03     
K+  0.59 0.56 -0.33 -0.41 0.47 
 P <0.01 <0.01 <0.01 <0.01 <0.01    
LS aBMD4 -0.01 0.10 -0.03 -0.03 -0.17 -.04  
 P 0.94 0.19 0.75 0.74 0.03 0.66   
TH aBMD 0.08 0.08 0.12 0.08 0.04 -.04 0.59  
 P 0.30 0.32 0.12 0.30 0.64 0.63 <0.01  
1 Potential Renal Acid Load (3,10), calculated according to formula 2. 2 Estimated Net 
Endogenous Acid Production (8), calculated using the ratio of protein to potassium intake 
according to formula 3. 3 Sulfur content of reported dietary protein sources, calculated 
according to formula 1. 4 Areal bone mineral density, g/cm2. Values are Spearman’s Rho and 
associated P values, n=161.
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Table 3.3. Regression of lumbar spine areal bone mineral density (aBMD, g/cm²) on protein 
and sulfur from protein, controlled for body weight1. 
  B SE ß P  
Entered in separate regression models:    
 Protein 1.11e-4 4.65e-4 0.02 0.81  
 Sulfur -1.35e-3 7.39e-4 -0.14 0.07  
Entered simultaneously, i.e., mutually adjusted:     
 Protein 1.35e-3 6.30e-4 0.22 0.04  
 Sulfur -2.82e-3 1.01e-3 -0.28 <0.01   
1 Estimated using ordinary multiple regression. Final model controlling for weight was 
determined using a step-down procedure removing age, physical activity, calcium and 
vitamin D intakes and an interaction of dietary protein with calcium. n=161 postmenopausal 
women.
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Figure 3.1. Scatterplot with least squares regression line and mean 95% CI of lumbar spine 
areal bone mineral density (aBMD, g/cm2) with protein, adjusted for associated sulfur intake 
(A) and with sulfur from protein, adjusted for total protein intake (B); n=161 postmenopausal 
women. Values are sample Z-scores, adjusted by ordinary multiple regression. Regressions 
were also controlled for body weight. For aBMD on protein, ß=0.21 (P=0.04). For aBMD on 
sulfur, ß=-0.28 (P<0.01). 
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Figure 3.2. Descriptive representation of median lumbar spine areal bone mineral density 
(aBMD) in 161 postmenopausal women with intakes above (high) and below (low) median 
intakes of protein and sulfur from protein. 
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Chapter 4 
Dietary protein holds IGF-1 mediated positive effects, as well as  
competing negative effects on bone health in rats 
 
Abstract 
The effect of high protein intakes on bone health is controversial, with both positive 
and negative effects reported. Human studies are clouded by correlations of protein, calcium 
and other factors.  
Sprague-Dawley rats (n=48) aged 52d were randomized to 10 wk diets: high protein 
(HP): 35% energy as casein, 40% as carbohydrate; normal protein (NP): 15% casein and 
60% carbohydrate. All other nutrients were matched. Measures included serum IGF-1 by 
RIA, mechanical strength of the femur midshaft by 3-point bend test, bone density by dual x-
ray absorptiometry and trabecular microarchitecture by micro-computed tomography.  
Energy intakes did not differ. No net differences in bone outcomes were observed 
between diet groups, except trabecular spacing (HP: 234±8, NP: 227±8 µm, p=0.023). 
However after covarying for IGF-1 in a mediational model, the high protein diet had a 
negative direct effect (standardized regression coefficient, -0.39 for ultimate stress, -0.45 for 
Young’s Modulus, -0.32 for Modulus of Toughness) that was opposed and negated by 
positive indirect effects (0.34 for ultimate stress, 0.35 for Young’s Modulus and 0.36 for 
Modulus of Toughness) mediated by IGF- 1 (all p <0.05). Opposing effects were roughly 
equal in magnitude, producing no net effect on bone strength.  
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Results are consistent with the hypothesis that protein has both positive effects, 
mediated by IGF- 1, and negative effects on bone health, but that the average total effect of a 
higher protein diet is null. 
Introduction 
Influences of protein intake on bone health have been historically controversial. 
Although the negative effect of protein deficiency on bone health is practically indisputable 
(1-3), many studies and reviews have supported both bone building (e.g., 1; 4) and bone 
degrading effects (e.g., 5) of high compared to normal protein intakes. A recent meta-
analysis (6) found a modest benefit, but in the context of highly variable results across 
studies.  
This variability of results may reflect a dual-nature of dietary protein’s influence on 
bone health. Above threshold adequate protein intakes determined by nitrogen balance (7), 
dietary protein imposes a metabolic acid load(8) and causes loss of calcium into urine (9). 
Alternatively, these higher protein intakes also increase intestinal calcium absorption (10) 
and increase circulating insulin-like growth factor (IGF) 1 (11; 12), a hormone regulating 
bone turnover and anabolism. Several authors including our lab have suggested that the net 
effect of dietary protein on bone health may depend on the relative balance of apparent bone-
building and bone-degrading influences (13-15).  
Specifically we observed that a positive association of protein intake with bone 
density of the lumbar spine was observed only after statistical adjustment for the negative 
association of the sulfur amino acid fraction of dietary protein in a sample of postmenopausal 
women (13). The positive and negative pathways were approximately equal in magnitude 
and opposite in direction, and so tended to negate one another when only the total association 
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of protein with bone density was observed. This type of association has been characterized 
statistically as a ‘suppressor effect’ (16), and appropriate statistical models have been 
developed for addressing this pattern of competing positive and negative pathways (17; 18). 
We concluded that investigations may miss real, simultaneous positive and negative effects 
of dietary protein unless statistical or experimental models address both the proposed positive 
and negative pathways (13). A similar pattern was observed in adolescents by Alexy et al. 
(14), where an otherwise positive effect of dietary protein was offset by a negative 
association of the dietary acid load. 
These epidemiological studies are limited in part by the complex nutrient interactions 
of a free-living diet. The present study seeks to clarify this theoretical dual relationship of 
dietary protein with bone health using an animal model and highly controlled diets, matched 
in all nutrients except the ratio of protein to carbohydrate. In order to evaluate the proposed 
competing positive and negative pathways, we measure IGF-1 and attempt to quantify how 
much, if any of the influence of dietary protein is mediated by IGF-1 levels. 
Methods 
Experimental model 
 Forty-eight female Sprague-Dawley rats (45 d old, body weight 135 ± 4.8 g, Harlan-
Tekland, Indianapolis, IN) were trained to consume a modified AIN-93 semipurified diet 
(19) as three meals per day, consisting of 3g of feed as “breakfast” (0700-0720 h) and 
unrestricted access to food at 1300-1400 h and 1800-1900 h. The baseline diet consisted of 
15% protein (casein), 12% lipid (soybean oil) and 63% carbohydrate (40% cornstarch, 10% 
sucrose and 13% maltodextrin) by weight. Each kg of diet also provided 0.014 g t-
Butylhydroquinone, 2.5 g choline, 50 g cellulose, 2.36 g cystine, 35 g of AIN93G mineral 
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mixture and 10 g AIN93G vitamin mixture. Water was provided ad libitum. Rats were 
individually housed in wire-bottom cages at  24°C in a 12 h light-dark cycle.  
 At 52 d of age, rats were randomly assigned to continue the baseline, control diet or 
to an isoenergetic experimental diet, matched in composition of all nutrients excepting the 
ratio of protein to carbohydrate. Specifically, the experimental diet replaced 21% of the diet’s 
weight from carbohydrate with an equal weight of casein. Accordingly, randomly assigned 
diets provided 60% energy as carbohydrate, 15% as protein and 25% as fat (CARB diet), 
compared to 40% carbohydrate, 35% protein and 25% fat (PRO diet).  
 Percent body fat was measured at 0 and 10 wks using small animal body composition 
settings using a Hologic QDR 4500A dual x-ray absorptiometer (Bedford MA). After 10 wk, 
animals were sacrificed, and left femurs were excised and stored in saline soaked gauze at -
20°C, a mode of storage demonstrated to not alter bone mechanical properties (20; 21). The 
University of Illinois Institutional Animal Care and Use Committee approved this protocol.  
Bone mineralization  
 Femora were thawed over 4 hours to room temperature and scanned with small 
animal bone settings using a Hologic QDR 4500A dual x-ray absorptiometer (Software 
version 11.2, Bedford MA) to measure areal bone mineral density (BMD, g/cm²) of the total 
femur.  
Bone strength 
 Following absorptiometry, femora were loaded to failure in a 3 point bend test using 
an Instron MINI 44 machine (Grove City, PA). Force was applied at the mid shaft along the 
anteroposterior axis. Strain rate was 0.6 mm/min, with a loading span of 15 mm. Following 
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fracture, digital calipers were used to measure the thickness of the cortical shell at 4 points, 
the midpoints of the quadrants created by intersection of the anteroposterior and mediolateral 
axes in cross section (see 22). Width of the shaft along anteroposterior and mediolateral axes 
were also measured. Cross-sectional moment of inertia (I) was approximated using an 
elliptical model as in Turner et al. (22): 
])2)(2()[64/( 33 tbtaabI −−−= π      eq. 1 
 where a is the mediolateral width, b is the anteroposterior width and t is the average 
cortical thickness from the four quadrants.  
 Force-displacement data from the bend apparatus were processed using custom 
programming by MP Thorpe in Matlab version 7.6.0. Ultimate force (Fu) is represented by 
the maximum force observed during bending, just prior to failure (complete breaking) of the 
bone. Stiffness (S) is the amount of force generated per unit of displacement prior to yield 
(partial breaking or loss of structural integrity of the bone), or the slope of the force-
displacement curve over the initial, non damaging region of the curve. Work to failure (U) is 
the energy absorbed by bone prior to complete fracture, or the area under the force-
displacement curve. Work to failure is frequently accepted as the single best indicator of 
overall bone strength (20; 22; 23). 
 Intrinsic biomechanical properties, or adjustments to the parameters described above 
to account for the physical dimensions of the bone, were derived using the following 
calculations, as in Turner et al. (22): 
Ultimate stress, ⎟⎠
⎞⎜⎝
⎛=
I
LbFuu 8
σ      eq. 2 
Young’s Modulus, ⎟⎟⎠
⎞
⎜⎜⎝
⎛=
I
LSE
48
3
     eq. 3 
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Modulus of Toughness, ⎟⎟⎠
⎞
⎜⎜⎝
⎛=
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bUuT 4
3 2      eq. 4 
 where again, I is the cross-sectional moment of inertia, b is the anteroposterior width 
and L is the loading span of the bend test (15 mm in this protocol).  
 After 3 point bend test to failure, the fractured, proximal portion of each femur was 
mounted vertically in a chuck and load was applied at 0.6 mm/min at the superior femoral 
head along an axis parallel to the shaft of the femur until failure of the femoral neck. The 
resulting force displacement curves were processed for ultimate force, stiffness and work to 
failure; however because the femoral neck is an irregular structure, no attempt was made to 
calculate intrinsic mechanical properties (22).  
Bone structure 
 In order to quantify the trabecular architecture of the bone, the distal portion of each 
fractured femur was scanned in a Skyscan 1172 micro computed tomographer using software 
version 1.5. A 1 mm Al filter was used to reduce beam hardening artifact through cortical 
bone. X-rays were applied at 74 kV source voltage and 100 µA current. Reconstructed image 
sets of 15.89 µm3 voxels were analyzed using Skyscan’s CTAn software and built-in 
trabecular analysis algorithms. The region of interest included 15 slices distal to the distal-
most point of the epiphyseal plate. Boundaries for the first and last slice this region were 
hand traced by the same investigator for all samples, and interpolated to the intervening 
slices. Intervening slices were then examined and adjusted as necessary such that analyzed 
regions included all and only trabecular bone. Voxels were segmented into bone or non-bone 
using a uniform grayscale value for all image sets. Analysis yielded mathematical estimates 
of average trabecular thickness (Tb.Th), number (Tb.N) and spacing (Tb.Sp) (24). 
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Insulin-like growth factor 1 
 IGF-1 was assayed using competitive binding of a radioactive ligand, [125I]-IGF-1, to 
polyclonal anti-human IGF-1 antibody (National Hormone and Pituitary Program, NIDDK, 
Torrance, CA). Concentrations were determined using a gamma counter (Packard 
Instruments, Meriden, CT) against a standard curve prepared from known concentrations of 
recombinant human IGF-1 (25). 
Statistical analysis 
 Ordinary least squares regression models were fit to quantify differences between 
PRO and CARB animals, using a dummy-code for diet assignment. Following initial tests, 
regression models were run again using IGF-1 concentration as a covariate in order to test its 
mediation of protein effects. The original estimate of the effect of diet on a bone outcome 
represents the total effect of the diet, whereas the change in this estimate after covarying for 
IGF-1 represents the portion of the effect of protein that is mediated, or explained by the 
effect of protein on IGF-1 (16; 26). This second estimate is also called the indirect effect, 
meaning the effect of protein that is indirectly channeled through the influence of IGF-1. 
Because estimates of the indirect effect do not have a single characteristic sampling 
distribution (17; 27), bootstrapping methods were employed to provide accurate confidence 
intervals (28) using the SPSS ‘INDIRECT’ mediation macro by Preacher and Hayes (29). 
For all statistics, α = 0.05. 
Results 
No differences in total food intake between diet groups were observed. No baseline 
differences in body weight were observed, but PRO rats were 4.3% heavier than CARB rats 
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at 10 wk (p<0.05). Percent body fat did not differ according to diet. We observed no total or 
net effect of diet on any outcome (Table 1); however when applying mediation models, we 
observed significant suppressor effects on several outcomes, with a negative direct effect of 
protein negating a positive indirect effect of protein mediated by IGF-1 concentrations (Table 
2).  
Specifically, IGF-1 concentrations were 75 µg/L (95% CI: 35,115) higher in PRO 
animals. Within mediation models, 1 SD increase in IGF-1 predicted an increase of 0.59 SD 
increase in ultimate stress, 0.60 SD in Young’s Modulus and 0.61 SD in Modulus of 
Toughness in 3 point bend testing; as well as a 0.58 SD increase in the CSMI (all p <0.05, 
see Table 2 for variance). Although not significant, values for femoral neck mechanical 
strength and trabecular thickness followed a comparable trend. No apparent influence of 
IGF-1 was observed for BMD, trabecular number or trabecular spacing. 
Within the mediation model, these positive effects of protein mediated by IGF-1 were 
negated by inverse associations between protein intake and bone outcomes in the covariance 
that was not explained by IGF-1 (Table 2; Figures 2-3). The protein diet exerted a significant, 
positive effect on trabecular spacing (lower values are desirable to prevent fracture); this 
effect was not negated by IGF-1. No significant interactions of IGF-1 with diet were 
observed for any outcome (all p>0.2). 
Discussion 
 We observed both positive and negative associations of the protein diet with bone 
outcomes when employing a mediational model. Mediational modeling is appropriate when 
multiple pathways are thought to exist between independent and dependent variables (16). 
With regards to bone health, multiple investigators have noted that higher protein appears to 
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hold a dual influence (15; 30; 31). In our prior, human study (13), we observed a positive 
association of protein with bone health after accounting for a negative, indirect effect of 
protein mediated by the sulfur amino acid content of protein. The mechanistic source of the 
positive effect was unexplained. In contrast, the present study demonstrated a marked 
negative influence of protein after accounting for a positive effect mediated by protein 
induced elevations in IGF-1. Although we are naturally reluctant to compare human 
epidemiology and experimental animal data too freely, it is striking that together these 
studies support the theory other authors have proposed, that the dietary acid load of protein 
and protein induced IGF-1 exert opposing effects on bone health (15; 30; 31). 
 The competing direct and indirect (IGF-1 mediated) pathways characterize a special 
case of statistical mediation known as a suppressor effect. As the name implies, a suppressor 
effect denotes direct and indirect pathways which cancel, or suppress one another. 
Suppressor effects are mathematically similar, but conceptually distinct from confounding 
effects: Although both may bias the estimate of the direct effect of the independent variable, 
a confounder is a third variable which would cause both protein intake and bone outcomes, 
resulting in a non-causal association between them. In contrast, the proposed suppressor 
effect is caused by protein intake and in turn causes a change in bone outcomes (16). 
Accordingly, while a confounder obscures the true relationship between independent and 
dependent variables, a suppressor is part of the true relationship and speaks to mechanism of 
the influence of protein.  
 Mediation and suppressor effects should also not be confused with statistical 
interactions. An interaction in this case would imply that the relationship of IGF-1 with bone 
outcomes differs between diets. As shown in Figures 2 and 3, no such interaction was 
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observed here and the influence of IGF-1 is parallel in PRO and CARB groups. In the 
observed mediational model, the influences of diet and IGF-1 are independent of one another 
and additive, such that CARB animals expressing high levels of IGF-1 have the highest bone 
strength, while PRO animals expressing low levels of IGF-1 have the poorest bone strength. 
However, because additional dietary protein itself increased IGF-1 levels, these extreme 
cases are relatively less common in our sample. Indeed, only 3 PRO animals were observed 
to have IGF-1 levels below the median for the sample, as a result of a well documented IGF-
1 response to increased dietary protein (32; 33). For this reason, the total effect of protein on 
bone health is approximately zero, implying that protein induced increases in IGF-1 
completely compensate for any negative effect of increased protein. 
 Our results are consistent with prior research and reviews suggesting that dietary 
protein imposes a mild, chronic metabolic acid load (34-38), that such a mild, chronic acid 
load can adversely affect calcium balance and bone metabolism (34; 39-43), but that actual 
bone outcomes in response to protein intake are stable or slightly improved (6; 35; 37; 44-
46). These data also support the proposition that IGF-1 explains or mediates some part of 
observed benefits of protein on bone outcomes (12; 32; 44; 47; 48). The practical 
implications are that a higher protein intake may benefit bone health if measures are taken to 
counter or reduce the associated metabolic acid load. Again, this is consistent with existing 
theory and evidence (15; 49-51). Indeed, Zerwekh et al. observed that apparently deleterious 
effects of a protein-induced acid load on bone were compensated by coadministration of 
alkali therapy in the form of potassium citrate (51). Also, if the suppressor effect observed in 
this study is generalizable, such an effect may mask statistical detection of positive and 
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negative pathways in studies that do not statistically or experimentally isolate proposed 
mediators of the influence of protein on bone.  
 Because IGF-1 levels were not experimentally manipulated, but allowed to respond 
naturally to diet, we cannot strictly conclude that elevated IGF-1 caused improvements in 
bone health. It is possible that some confounding factor increases the propensity of IGF-1 to 
respond to protein as well as bone strength. We consider this possibility unlikely in light of 
the well established role of IGF-1 in bone growth and turnover. A second limitation is that 
this experiment was not designed to evaluate the influence of IGF binding proteins, which 
may be regulated by protein intake (33) and modify effects on bone health (52). 
 In conclusion, we observed a null total effect of a higher protein relative to a normal 
protein diet on bone health in rats. Mediation analysis indicated that a positive, indirect effect 
of dietary protein, mediated by increasing circulating levels of IGF-1, cancels out an 
otherwise negative influence of high protein through an untested mechanism. The results are 
consistent with a competing pathways model of protein and bone health, and may clarify 
why, as observed by Tucker (35), “The role of protein [in bone health] appears to be complex 
and is probably dependent on the presence of other nutrients available in a mixed diet.”  
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Table 4.1. Insulin-like growth factor 1 (IGF-1), bone mineral density (BMD), cross sectional 
moment of inertia (CSMI) and femur mechanical strength and structure in rats fed normal 
protein (NP) or higher protein (HP) diet. 
Mean ± SD NP HP p 
 IGF-1, µg/L 190 ± 39 266 ± 61 0.001 
 BMD, mg/cm² 210 ± 10 206 ± 9 0.362 
 CSMI,  4.04 ± 0.57 3.98 ± 0.52 0.775 
3 point bend test of the femoral midshaft 
 Ultimate Stress, MPa 2.58 ± 0.62 2.54 ± 0.58 0.829 
 Young’s Modulus, GPa 8.06 ± 1.58 7.79 ± 1.58 0.653 
 Modulus of Toughness, MJ/m³ 18.3 ± 6 18.7 ± 6.9 0.860 
Femoral neck bend test 
 Ultimate Load, N 91.9 ± 15.8 82 ± 9.7 0.060 
 Work to Failure, mJ 42.2 ± 16.3 35.4 ± 7.8 0.184 
Micro computed tomography, trabecular morphometry 
 Thickness, µm 119 ± 9 117 ± 7 0.439 
 Number, mm-1 2.96 ± 0.21 2.87 ± 0.21 0.258 
 Spacing, µm 227 ± 8 234 ± 8 0.023 
 
Table 4.2. Mediation model parameters for the direct and indirect (IGF-1 mediated) 
associations of diet (higher protein vs. normal protein) with bone health parameters. Values 
are regression coefficients (95% CI) a. 
Outcome Direct diet effect b Indirect (IGF-1 mediated) effect c 
 BMD, mg/cm² 0.24 (-0.66, 0.33) 0.01 (-0.34, 0.34) 
 CSMI 0.24 (-0.90, 0.09) 0.34 d (0.11, 0.70) 
3 point bend test of the femoral midshaft   
 Ultimate Stress, MPa 0.24 (-0.89, 0.11) 0.35 d (0.11, 0.72) 
 Young's Modulus, GPa 0.24 (-0.95, 0.05) 0.35 d (0.09, 0.71) 
 Toughness, MJ/m³ 0.22 (-0.77, 0.12) 0.36 d (0.10, 0.73) 
Femoral neck bend test   
 Ultimate Load, N 0.19 (-0.73, 0.03) 0.04 (-0.20, 0.27) 
 Work to Failure, mJ 0.17 d (-0.70, 0.004) 0.14 (-0.04, 0.35) 
Micro computed tomography, trabecular morphometry   
 Number, mm-1 0.26 (-0.83, 0.24) 0.05 (-0.38, 0.38) 
 Thickness, µm 0.24 (-0.91, 0.08) 0.26 (-0.02, 0.60) 
 Spacing, µm 0.23 d (0.07, 1.02) -0.10 (-0.33, 0.23) 
a Mediation analysis performed using INDIRECT macro for SPSS by Peacher & Hayes (29). 
The total or net effect of higher protein diet membership is the sum of direct and indirect 
effects, and in these data, were not significant except for trabecular spacing (see Table 1).  b 
Coefficents reflect the predicted standardized change in outcome for animals fed high 
protein, vs. normal protein diet. c Standardized coefficients reflect predicted change in 
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outcome for each 1 SD increase in circulating IGF-1 (SD = 64 µg/L) . d Statistically 
significant (p<0.05).
Figure 4.1. A mediational model of the influence of protein on bone health a. 
 
a Mediation models are analyzed by testing the effect of x on y with and without covarying 
for the proposed mediator, m. The total effect is the influence of protein on bone outcomes 
without regard to IGF-1. After covarying for IGF-1, the direct effect is the effect of protein 
on bone outcomes, statistically adjusted for IGF-1. The indirect effect is the part of the 
influence of protein on bone that is mediated by IGF-1, and is represented by the product of 
the effect of protein on bone with the effect of IGF-1 on bone (26). A suppressor effect is a 
special case of mediation, where the direct and indirect effect are opposite in direction, and 
therefore negate or ‘suppress’ one another.
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Figure 4.2. Femur shaft strength is poor in PRO fed animals with IGF-1 levels below the 
median, relative to PRO fed animals with IGF-1 levels above the median and relative to 
CARB fed animals. 
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Figure 4.3. Femur neck strength is poor in PRO fed animals with IGF-1 levels below the 
median, relative to PRO fed animals with IGF-1 levels above the median and relative to 
CARB fed animals. 
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Chapter 5 
Lean body mass mediates the influence of  
protein source on bone health 
 
Abstract 
Studies of protein and bone health report variable results. Differential effects of 
protein sources may explain incongruities. In particular, sulfur amino acids may impose a 
bone-demineralizing acid load while aromatic amino acids may enhance calcium balance. 
Protein may also improve body composition, which in turn positively influences bone health.  
We randomized 52, 52 d old rats to semi-purified, isonitrogenous diets (16% energy 
as protein, 54% carb) with protein isolate from soy, egg white + lysine, wheat or whey. Total 
energy was restricted to 80% of ad libitum intake. Animals were sacrificed at 11 wk, and 
femurs excised for 3 point bend tests of mechanical strength, dual x-ray absorptiometry 
(DXA) and micro-computed tomography (µCT).  
In spite of 20% energy restriction, weight gain was approximately normal for all 
animals. Greater force was required to break the femur midshaft with whey (119±10 N) 
compared to soy (110±9 N, p=0.02). Bone mineral mass was also greater given whey 
(480±25 mg) vs. egg (466±14 mg) and soy (456±27 mg). Differences in bone strength and 
mass dissolved after statistically adjusting for differences in lean body mass between groups, 
suggesting lean body mass was the principle mediator of protein effects on bone parameters. 
Lean body mass completely mediated the influence of protein source on bone health 
in rats during modest energy restriction, independently of total protein and energy intake. 
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Introduction 
Dietary protein may influence bone health through various pathways (1). The acid 
load of protein varies in proportion to the amount of sulfur containing amino acids (SAA), 
which differ twofold across various common dietary protein sources (2). This SAA induced 
acid load elevates urinary calcium (3; 4), which may reflect bone demineralization in 
response to mild acidosis (5; 6). Alternatively, it has been shown that dietary protein 
increases calcium absorption (7; 8), and this effect may also vary in proportion to specific 
source-dependent amino acids (9; 10). Finally, we have previously shown that protein 
sources rich in leucine positively regulate lean body mass (11), which is consistently 
associated with bone health, perhaps causally through increased loading of bone tissue (12).  
The net effect of dietary protein on bone may be positive (1; 13) or negative (14). 
This discrepancy may be attributable to the protein source (1), including the specific fractions 
of SAA, leucine or the cluster of amino acids thought to regulate the calcium sensing 
receptor, CaR (15). In this context, the present study evaluates the influence of protein 
isolates from wheat, soy, egg and whey on the mineral mass, mechanical strength and 
trabecular microarchitecture of bone in rats. In light of prior studies (4), we anticipate that 
bone parameters will correspond inversely with the SAA content of the protein source. 
Methods 
Fifty-two male Sprague-Dawley rats (52d old, 275±10g, Harlan-Tekland) were 
randomly assigned to a semi-purified, isonitrogenous diet providing protein isolate from 
wheat, soy, egg or whey. Diets provided 16% energy as protein and 54% as carbohydrate 
(Tables 1 and 2). Diets were based on the AIN-93 rodent diet (16). Animals were fed 80% of 
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their ad libitum food intake (80% of 18g/d) as 4 g between 0700 and 0720, 4 g between 1300 
and 1400 and 6 g between 1800 and 1900. This schedule was developed to mimic human 
meal patterns (17). Mild energy restriction (80% of average ad libitum intake) was employed 
to ensure similar total food intakes across animals. Water was given ad libitum and animals 
were housed individually at 24°C in wire-bottom cages over a 12 h light-dark cycle. 
  Following 11 weeks on the experimental diets lean body mass was measured via 
Hologic QDR 4500A dual x-ray absorptiometer (Bedford, MA) using small animal body 
composition scans. Animals were then sacrificed and excised femurs were stored in saline 
soaked gauze at -20°C. Storage in this manner has been shown not to affect material 
properties of rodent femora (18). Oversight and approval for this protocol was provided by 
the University of Illinois Institutional Animal Care and Use Committee. 
Bone densitometry and mechanical strength testing 
 Right femora were thawed to room temperature and scanned using small animal bone 
settings on a Hologic QDR 4500A bone densitometer (version 11.2). Femurs were then 
tested to failure in 3 point bending at the mid shaft in an anteroposterior axis using an Instron 
MINI 44 (Grove City, PA) bend apparatus. Loading span was 20 mm and load rate was 0.6 
mm/min. Average cortical thickness at the plane of fracture was estimated using by digital 
calipers at 4 sites around the cortical rim, and the cross-sectional moment of inertia (I) was 
approximated using the formula described by Turner (19) for approximating I of an ellipse: 
])2)(2()[64/( 33 tbtaabI −−−= π      eq. 1 
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a is the mediolateral width and b is the anteroposterior width of the bone at the cross section 
of fracture, and t is the average cortical thickness. 
 Ultimate force (Fu) or maximum force observed during loading, just prior to 
complete fracture; stiffness (S) or the slope of the force displacement curve prior to bone 
yielding; and the work to failure (U) or area under the force displacement curve were derived 
from the force displacement curve using Matlab version 7.6.0. Physical dimensions of the 
bone were then used to calculate intrinsic parameters as follows (19): 
Ultimate stress, ⎟⎠
⎞⎜⎝
⎛=
I
LbFuu 8
σ      eq. 2 
Intrinsic stiffness (Young’s Modulus), ⎟⎟⎠
⎞
⎜⎜⎝
⎛=
I
LSE
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Modulus of Toughness, ⎟⎟⎠
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3 2      eq. 4 
 The intact proximal half of the femur following 3 point bend testing was mounted 
vertically using a chuck and the head of the femur was loaded to failure of the femoral neck, 
again at a rate of 0.6 mm/in, along a parallel axis to the femur shaft. Fu, S and U were derived 
from the resulting force displacement curves, however no intrinsic mechanical properties 
were calculated due to the irregular shape of the femoral neck. 
Micro computed tomography 
 The distal half of the broken femur was scanned with a Skyscan 1172 (Skyscan, 
Aartselaar, Belgium) micro computed tomographer (µCT) with acquisition software version 
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1.5. A 1 mm aluminum filter was employed to reduce beam hardening artifact of the final 
images. Five frame averaging was used to reduce noise. Scans were performed using 74 kV 
source volage and 100 mA current. Reconstruction of projections was performed with 
NRecon software (Skyscan), for a resulting voxel size of 16 µm3. The volume of interest was 
defined in CTAn software (Skyscan) by hand tracing the first and last slices of the range 
within 0.79 mm proximal to the proximal-most point of the growth plate. The volume of 
interest between the first and last slice were initially interpolated from these tracings, and 
then corrected as necessary such that analyzed bone within each slice consisted of only the 
trabecular bone space inside the cortical rim. Within the volume of interest images were 
binarized, leaving every voxel defined as bone or non-bone using an intensity threshold of 55 
on a 256 intensity scale. CTAn software calculated volume of bone, % bone tissue within the 
region of interest and the average number, spacing and thickness of trabeculae within this 
volume. 
Statistics 
 In order to allow comparisons of protein source on bone outcomes while covarying 
for combinations of other body composition variables, we analyzed outcomes using 
regression analysis and dummy coded protein source assignments for protein source (20). 
Dummy coded regression coefficients reflect the difference between their respective protein 
sources and the grand sample mean. Where covariates are included, dummy coded 
coefficients represent the model predicted effect of the protein source, holding the covariate 
constant. This approach allowed for flexible modeling of the data, such that main effects of 
protein source, correlations with body composition and the potential role of body 
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composition as a mediator of protein’s effect on bone health could be tested through the same 
underlying model (21). 
Results 
 In spite of modest weight restriction, rats followed an approximately normal growth 
curve over 11 week; however differences in weight emerged by endpoint testing (Table 3). 
Results for bone outcomes are also presented in Table 3. We observed improvements in bone 
strength and bone mineral content in whey animals, and slight decreases in soy fed animals. 
Other protein groups did not differ. Wheat protein additionally improved some measures of 
trabecular structure, but these changes did not confer an improvement in bone strength. 
 Protein source increased weight gain relative to soy, and also similarly increased lean 
body mass in the whey group (Table 3). Statistical models investigating the role of body 
composition on bone outcomes indicated that weight, lean body mass and percent body fat 
were predictive of bone outcomes (Table 4). Note that weight, body fat and lean body mass 
are never reported in the same model, due to the high degree of mutual information in these 
variables (R=0.69 for weight and lean body mass, 0.52 for weight and fat mass, all p<0.05). 
Overall, lean body mass was observed to have the strongest positive effect on bone health, 
with weight (which was predominantly lean mass) also exhibiting positive effects. Body fat 
was negatively related, though the association was weak. 
 A mediation analysis was performed to assess the degree to which body composition 
explained the observed changes to strength and mineralization. Upon adjusting the effects of 
protein source on bone outcomes for the concurrent effects on lean body mass, the significant 
effects of whey and soy were abolished. This result indicates that in this experiment, the 
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effect of whey relative to soy protein on bone health was completely mediated by body 
composition (21). 
Discussion 
 Whey protein increased bone strength and mass, and soy protein reduced these 
parameters; however these differences appear to be completely attributable to changes in 
body composition, especially lean body mass. No changes were observed in intrinsic bone 
properties, which is consistent with the finding that body size accounts for increases in bone 
strength. Similarly, bones were increased in mass and area, but not density. Wheat protein 
conferred some benefit to trabecular architecture, although these were not associated with 
improved bone strength in this group. Our results do not support the theory that the acid load 
imposed by sulfur containing amino acids negatively affects bone health. They are also 
inconsistent with the theory that aromatic amino acids improve calcium balance or bone 
metabolism. It is possible, but not knowable, that effects of these amino acids were masked 
by more prominent regulation by body composition. The most important implication of these 
data is that changes in body composition mediate the influence of protein source on bone.  
 Our results are analogous to those of Pye et al (22), who studied rats consuming 15 or 
35% of energy from protein, with egg albumen and skim milk powder constituting the 
difference, over a time span up to 17 mo. They report a benefit to weight adjusted regional 
bone mineral content but no effect of protein on bone turnover, mechanical strength or 
trabecular architecture. In addition they observed a dramatic reduction in body weight and 
particularly fat mass with an increase in lean mass in response to higher protein intake. In 
light of the correspondence of bone strength with body mass, it is noticeable that the higher 
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protein intake preserved bone strength in the face of decreased weight in that study. Although 
levels or protein intake were not compared in the present study, we likewise observe that 
effects of protein source on bone health in rats can be explained in no small part by changes 
in body composition. 
 The element of energy restriction in this study is important to bear in mind. Intakes at 
80% of ad libitum amounts were sufficient to promote growth while allowing assurance of 
equal total calorie and protein intakes across groups, but it is possible that energy restriction 
moderates the influence of protein source. Mardon et al. studied the influence of protein and 
energy restriction in rats. They report expected adverse effects of 40% energy restriction on 
bone that is not compensated by normalization of protein intake or by substitution of whey 
protein for casein (23). In another study, however, they report that supplementation of protein 
intake was able to recover part of the calcium accrual otherwise lost with energy restriction 
in growing rats (13). In both of these studies, levels of insulin-like growth factor 1 (IGF-1) 
were reduced with protein and/or energy restriction, which may mediate some part of the 
detrimental changes to bone (24; 25). 
Dawson-Hughes et al. (9) reported that aromatic amino acids (AAA) increased IGF-1 
relative to branched chain amino acids administered as supplemental isolates in humans, 
suggesting a possible role for protein sources differing in the AAA load in regulation of bone 
growth. Conigrave (15) reviews preliminary evidence that AAA may influence multiple 
aspects of bone health as potentiators of the calcium sensing receptor, CaR. Our data do not 
support this, as AAA was unable to explain the observed changes; however the five-fold 
increase in AAA intake in that investigation may also have been larger than may be 
reasonably achieved through typical selection of protein sources. 
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 Whiting and Draper (26) showed that rats fed sulfur amino acids (SAA) exhibited 
bone damage over time, while no such effect was observed in rats consuming protein with 
equivalent amounts of SAA. They also showed SAA to be primarily responsible for the well 
documented increase in urine calcium in response to protein intake (27). These observations 
supported the concept that the dietary acid load associated with sulfur amino acids (28) is 
damaging to bone (29-31). It is indeed known that SAA are responsible for perturbations in 
acid-base balance (32; 33) and that a dietary acid load is damaging to bone (34-36). We have 
previously proposed that protein intakes may be beneficial to bone in the context of a diet 
that is adequate in calcium (37) or relatively low in SAA (1). However, as with AAA, the 
present data offer no support for the role of SAA in mediating protein influences. 
 It has alternatively been proposed that dietary protein above adequate thresholds 
increases lean body mass (38; 39), and that lean body mass in turn improves bone health 
(40). Frost (12) has suggested that muscle mass, moreso than body weight per se, is 
responsible for the mechanical loading of bone and its remodeling to meet that demand. 
 Limitations of this study include a relatively short duration in terms of bone 
adaptation, and the absence of plasma indices of bone health and the high variability 
observed in some measures of bone fragility and trabecular structure, which may have made 
some true treatment effects more difficult to detect. Energy restriction was both limiting in 
that we cannot necessarily generalize our result to ad libitum intakes, and a strength in that it 
ensured that observed differences in bone and body composition were consequences of 
protein source, and not total protein or energy intake. 
 In summary, we do not observe effects of protein source on bone in proportion to the 
fraction of SAA or AAA; however these effects may have been masked by a more important 
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influence of lean body mass. Improvements in lean body mass with whey compared to soy 
protein during modest restriction of energy completely explains an increase in bone mass and 
strength. Again, we suggest that body composition mediates the relationships between 
dietary protein and bone health. Accordingly, body composition should be accounted for in 
studies of protein and bone.
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Table 5.1. Composition of animal diets, g nutrient/kg feed 1 
Component Wheat Diet Soy Diet Egg Diet Whey Diet
Vital Wheat Gluten 190.2 0.0 0.0 0.0
Soy Protein Isolate 0.0 185.3 0.0 0.0
Egg White Solids 0.0 0.0 195.6 0.0
Whey Protein Isolate 0.0 0.0 0.0 188.8
L-Lysine 10.1 0.0 0.0 0.0
Cornstarch 316.7 331.7 321.4 328.2
Maltodextrin 134.1 134.1 134.1 134.1
Sucrose 101.5 101.5 101.5 101.5
Soybean Oil 140.9 140.9 140.9 140.9
Cellulose (Fiber) 53.7 53.7 53.7 53.7
AIN-93 Mineral Mix 37.6 37.6 37.6 37.6
AIN-93 Vitamin Mix 10.7 10.7 10.7 10.7
Choline Bitautrate 2.7 2.7 2.7 2.7
Biotin (mg/kg) 0.0 0.0 16.0 0.0
1 Table prepared by Layne Norton. Not yet published, used with permission. 
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Table 5.2. Amino acid content of diets, g/kg diet, and NRC requirements1,2,3 
Amino Acid Wheat 
Diet 
Soy Diet Egg Diet Whey 
Diet 
NRC 
Requirement1
Phenyalanine/Tyrosine 11.5 17.0 16.8 10.7 1.9 
Histidine 3.1 4.2 3.9 3.4 0.8 
Isoleucine 5.1 8.1 9.0 10.5 3.1 
Leucine 11.5 13.6 14.9 18.5 1.8 
Lysine 15.4 10.7 11.0 15.4 1.1 
Methionine/Cysteine 6.5 4.4 13.9 7.6 2.3 
Threonine 4.4 6.5 7.6 10.9 1.8 
Tryptophan 2.2 2.0 2.7 2.7 0.5 
Valine 7.6 8.0 11.5 10.2 2.3 
1 Table prepared by Layne Norton. Not yet published, used with permission. 
2 Table 2-2 from Nutrient Requirements of Laboratory Animals Fourth Revised Edition (41). 
3 Requirements estimated for a 300 g rat in weight maintenance. 
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Table 5.3. Body composition, bone mineralization, bone biomechanical properties and 
trabecular architecture, mean ± SD, according to protein source.  
  Soy Whey Wheat Egg 
Body composition, scales and dual x-ray absorptiometry 
 Weight, g 368±7 a 382±11 392±9 a 378±10 
 Fat Mass, g 37.4±9.2 36.9±10.6 48.5±7.8 a 36.8±5.1 b 
 Lean mass, g 330±8 a 345±11 344±11 341±9 
 Body Fat, % 10.2±2.4 9.6±2.7 12.3±2 a 9.7±1.3 b 
Bone mineralization, dual x-ray absorptiometry 
 Mineral Content, g 0.46±0.03 a 0.49±0.03 a 0.48±0.03 0.47±0.01 
 Density, g/cm² 0.26±0.01 b 0.26±0.01 0.26±0.01 0.26±0.01 
 Area, cm² 1.78±0.07 a 1.85±0.07 a 1.82±0.06 1.8±0.04 
Trabecular architecture, micro computed tomography 
 Bone volume, % 9.6±2.6 9.1±1.5 10.9±3.1 a 8.2±2.1 b 
 Thickness, µm 91±4 91±3 93±6 89±5 b 
 Spacing 462±48 473±37 446±52 b 482±30 
 Number 1.04±0.25e-3 1.00±0.15e-3 1.17±0.28e-3
a 0.92±0.21e-3b 
      
 
 
 
 
105 
106 
Table 5.3 (cont.) 
  Soy Whey Wheat Egg 
Bone mechanical strength, femoral neck and 3 point bend test 
 Neck Fu, N 82±7 82±11 82±9 80±8 
 Neck U, mJ 33±9 36±13 34±10 34±8 
 Neck S, N/mm 192±30 166±36 b 193±32 173±30 
 Fu, N 110±9 a 119±11 a 114±10 115±5 
 U, mJ 56±9 60±16 60±8 60±8 
 S, N/mm 226±15 238±14 a 226±24 228±17 
 Ultimate Stress, MPa 154±11 157±10 158±9 159±11 
 E, mJ 6.67±0.44 6.63±0.56 6.65±0.54 6.65±0.75 
 Ut, MJ/m^3 48.5±12.6 56.2±21.9 50.2±11.6 51.4±7.4 
a Mean differs from grand sample mean (p<0.05) based on dummy coded regression analysis, 
prior to adjustment for covariates. b Mean exhibits a non-significant trend (p<0.1) for 
difference from the grand sample mean. 
Table 5.4. Unstandardized (B) and standardized (ß) regression coefficients for the prediction 
of ultimate force (N change per g change in weight, lean body mass or fat mass) and bone 
mineral content (mg change per g change in weight). 
 Ultimate Force Bone Mineral Content 
Independent 
Variable 
B±SE ß p B±SE ß p 
Weight  0.21±0.1 0.29 0.04 0.85±0.27 0.42 0.00 
LBM 0.31±0.11 0.37 0.01 1.48±0.26 0.65 0.00 
Fatmass -
0.05±0.14 
-0.05 0.74 -0.55±0.39 -0.20 0.16 
LBM,  
covaried for weight 
0.27±0.15 0.33 0.09 1.57±0.36 0.68 0.00 
Fat mass,  
covaried for weight 
-
0.27±0.15 
-0.27 0.09 -1.57±0.36 -0.58 0.00 
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Table 5.5. Effect of protein source on ultimate force (N) and bone mineral content (mg) 
before and after adjustment for body composition. Standardized (B) and unstandardized (ß) 
regression coefficient. 
  Soy   Whey   
  B±SE ß p B±SE ß p 
Bone Mineral Content, change in mg, adjusted for body composition 
 Effect of Protein 
Source 
-20.6±7.7 -0.35 0.010 20.1±7.8 0.34 0.013
 Weight adjusted -11.3±9.3 -0.19 0.229 19.9±7.5 0.33 0.011
 Lean body mass 
adjusted 
-3.3±7.6 -0.06 0.668 13.3±6.7 0.22 0.052
Ultimate Force, change in N, adjusted for body composition 
 Protein Source -5.8±2.8 -0.28 0.046 6±2.838 0.29 0.038
 Weight adjusted -4.1±3.5 -0.20 0.242 5.7±2.893 0.27 0.056
 Lean body mass 
adjusted 
-3.1±3.3 -0.15 0.340 4.5±2.926 0.21 0.132
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Figure 5.1. Bone mineral content in response to protein source. 
 
Means and 95% confidence intervals are depicted, with small dots representing individual 
data points. a Group differs from grand sample mean, p<0.05, based on dummy coded 
multiple regression. These effects are abolished after statistically adjusting for the positive 
effect of weight. 
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Figure 5.2. Ultimate force, or force at breaking, in response to protein source. 
 
Means and 95% confidence intervals are depicted, with small dots representing individual 
data points. a Group differs from grand sample mean, p<0.05, based on dummy coded 
multiple regression. These effects are abolished after statistically adjusting for the positive 
effect of lean body mass. 
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Chapter 6 
A diet high in protein, dairy and calcium attenuates bone loss  
over 12 months of weight loss and maintenance 
 
Abstract 
Weight loss causes bone mineral loss. Higher protein diets remain criticized for 
further potential harmful bone effects, including elevated urinary calcium, but may promote 
bone health if protein sources include dairy. Overweight middle-aged subjects (n=130, 59 
males) were randomized to a diet providing 1.4 g/(kg·d) protein and 3 daily servings of dairy 
(PRO) or 0.8 g/(kg·d) protein and 2 daily servings of dairy (CARB) for 4 mo weight loss plus 
8 mo weight maintenance. Diets prescribed 6,276 kJ/d for females and 7,113 kJ/d for males. 
Bone mineral content (BMC) and density (BMD) for whole body (WB), lumbar spine (LS) 
and total hip (TH) were measured using dual X-ray absorptiometry (DXA), and dietary 
intake using 3-d weighed food records. Urinary calcium was measured using 24-hour 
collection at 0 and 8 mo for a subsample (n=42). Participants lost body weight (mean, 95% 
CI) of 8.2% (7.5-8.9) at 4 mo, 10.6% (9.5-11.8) at 8 mo and 10.5% (8.9-12.0) at 12 mo 
without differences between groups at any time (P=0.64). At 12 mo, PRO BMD was higher 
by 1.6% (0.3-3.0) at WB, 2.1% (0.6-3.7) at LS and 1.4% (0.2-2.5) at TH compared to CARB. 
PRO calcium intake was higher (PRO: 1140±58 mg/d, CARB: 766±46, P<0.01), as was 
urinary calcium (PRO:163±15 mg/d, CARB:100±9.2, P<0.01). A reduced energy diet 
supplying 1.4 g/(kg·d) protein and 3 dairy servings increased urinary calcium excretion but 
provided improved calcium intake and attenuated bone loss over 4 mo of weight loss and 8 
additional mo of weight maintenance. 
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 Introduction 
Weight loss has well-established, favorable effects on metabolic disease risk such as 
type 2 diabetes mellitus and cardiovascular disease in overweight populations (1); however, 
weight loss also promotes loss of bone mass and increases fracture risk (2-4). As an aging 
population confronts concurrent threats of obesity and osteoporosis, diets that promote 
weight loss while maintaining bone mineral are of special interest. 
Higher protein weight loss diets have received attention due to purported 
improvements in adherence and body composition, including enhanced loss of fat mass and 
preservation of lean mass (5-7). Recent prospective and clinical trials suggest that higher 
protein diets, if accompanied by adequate calcium, enhance bone health (8-11). This remains 
controversial in light of longstanding theory and evidence that increasing protein intakes 
promote calciuria (12). Increased urinary calcium with greater protein intake is traditionally 
considered to reflect bone demineralization; however, Kerstetter et al. (13) have shown that 
additional dietary protein promotes intestinal calcium absorption and reduces the fraction of 
urinary calcium of bone origin. Dawson-Hughes (14) has proposed that the net effect of 
dietary protein on bone mineral status depends on dietary availability of calcium. 
In light of these observations, we propose that a diet utilizing dairy foods as a source 
of both protein and calcium will preserve bone mineral density (BMD) and content (BMC) 
relative to a conventional higher carbohydrate weight loss diet. We have adopted a free 
living, freely selected diet approach in which patients are educated on selection of food 
groups rather than directly controlling intakes of individual nutrients. This design is oriented 
to prove effectiveness, rather than efficacy. That is, our design will not resolve the 
independent or interactive effects of dietary protein and calcium on bone health during 
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weight loss, however the design is more generalizable to clinical practice than highly 
controlled feeding studies, and more directly answers the question most relevant to the 
clinical practitioner: “What is the effect on bone health of prescribing a higher protein weight 
loss diet emphasizing dairy?”  
The primary aim of this study was to compare bone mineral content (BMC) and 
density (BMD) during 4 mo of active weight loss and 8 additional mo of weight maintenance 
in free-living participants on a diet providing 1.4 g/(kg·d) protein and 3 dairy servings (PRO) 
compared to an isocaloric, conventional weight loss diet providing 0.8 g/(kg·d) protein 
(CARB). Based on previous work we anticipated increased protein and calcium intakes, 
elevated urinary calcium excretion and attenuated bone loss in PRO compared to CARB 
participants. 
Subjects and Methods 
One-hundred-thirty subjects (59 males) aged 30 and 65 y (mean ± SD: 45.6 ± 8.9 y) 
were recruited to a 12 month randomized, parallel-arm, multi-center (Illinois and 
Pennsylvania sites) weight loss trial. Exclusion criteria were as follows: BMI below 26 
kg/m2, body weight exceeding 140 kg (due to constraints of the DXA scanning bed), 
smoking and conditions or medications affecting study outcomes, including cancer, heart 
disease, diabetes mellitus, renal disease or insufficiency, major weight change in the prior 6 
mo or use of bone active medications or supplements, oral steroids or anti-depressants. 
Participants were blocked into groups of similar age and BMI, then blocks were randomly 
divided into PRO or CARB diets. Institutional Review Boards of the University of Illinois at 
Urbana-Champaign and The Pennsylvania State University approved all methods; subjects 
provided written informed consent. 
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Treatments 
The PRO diet prescribed 1.4 g/(kg·d) protein, 3 daily servings of dairy and roughly 
30, 40 and 30% of energy respectively from protein, carbohydrate, and fat (ratio of 
carbohydrate to protein < 1.5). The CARB diet prescribed 0.8 g/(kg·d) protein, 2 daily 
servings of dairy and roughly 15, 55 and 30% of daily energy respectively from protein, 
carbohydrate, and fat (ratio of carbohydrates to protein > 3.5). Both diets prescribed 6,276 
kJ/d for females and 7,113 kJ/d for males, and equal total fat (~ 57 g/d) and fiber (~ 17 g/d). 
Subjects were asked not to take any dietary supplements during the study. 
Research dietitians instructed participants on portion sizes and emphasized the Food 
Guide Pyramid (15) for the CARB group, and replacement of starchy staples (breads, rice, 
pasta, cereals) with meats, eggs and dairy for the PRO group. Participants were provided 2-
week cycling menu plans. Each diet prescribed micronutrient intakes meeting Recommended 
Dietary Allowances (RDAs) (16), fat intake meeting guidelines by the American Heart 
Association (17), and 5 servings of vegetables and 2-3 servings of fruit daily. Participants 
reported 1 hr weekly  for support, questions and answers, review of diet records and 
compliance, submission of 3-day weighed food records, and body weight measurement. 
Mean intakes at 0, 4, 8 and 12 mo were calculated with Nutritionist Pro software (First 
DataBank Inc., San Bruno, CA), and averages were used for analysis of dietary compliance 
and nutrient intakes. Participants were encouraged to spend at least 30 min walking 5 d 
weekly according to NIH Guidelines for Weight Management (1). Activity was monitored 
using daily logs and 3 d/mo using armband accelerometers (BodyMedia, Cincinnati, OH). 
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Bone and body composition 
 Whole body (WB), lumbar spine (LS) and total hip (TH) DXA scans were performed 
at 0, 4, 8 and 12 mo (Illinois: Hologic QDR 4500A, software version 11.1:3; Penn State: 
Hologic QDR 4500W, software version 12.5). Scans for a given individual were analyzed by 
the same technician at each site using standard manufacturer guidelines. The same array scan 
mode was used for all central measure scans. DXA machines were calibrated daily using 
manufacturer phantoms. Analyzed LS data included L1–L4. Volunteers wore light, metal-
free, cotton clothing. CVs for DXA outcomes of interest are 1.0 to 2.0%.  
Urinary calcium measures 
Twenty-four hour urine samples were collected at baseline and at 8 mo from Illinois 
participants. Forty two Illinois participants remained in the study at 8 months, providing 
complete urinary calcium data. Ten ml aliquots of mixed collections were diluted and tested 
by atomic flame absorption spectroscopy, using a Perkin-Elmer 306 atomic absorption 
spectrophotometer to determine calcium concentration. 
Statistical analysis 
SPSS version 14 (SPSS, Inc., Chicago, IL) provided all statistical analyses. Normality 
assumptions were tested by the Shapiro-Wilk statistic. Reported values are mean ± SEM for 
normally distributed variables, and median (inter-quartile range, IQR) for non-normally 
distributed variables. Baseline characteristics, weight change and intakes are compared using 
ANOVA. Linear mixed models with random slopes and time of measurement as a repeated 
effect were applied to BMC and BMD at the three measurement sites (WB, LS, TH) in 
intent-to-treat fashion, adjusted for baseline values and gender, site of study participation and 
two- and three- way interactions of gender and study site with diet and time. We also tested 
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tertiles of age among female participants to indirectly control for menopausal status. Dietary 
treatment effects on urinary calcium measures at 8 mo were analyzed using ANCOVA, 
controlling for baseline urinary calcium and gender. ANCOVA was also employed to assess 
whether elevated urinary calcium excretion was related to BMC within dietary treatment 
groups. Additional details of the statistical analysis may be found in the supplemental 
material. 
Results 
At baseline PRO females were lower in WB BMD compared to CARB females 
(Table 1) and CARB males reported smaller energy and macronutrient intakes compared to 
PRO males (Table 2, Supplemental Table 1). Subjects were otherwise similar across groups. 
One extreme, lone outlier (sample Z score < -3.5 or > 3.5 without skew) was identified in 
both BMC and BMD at the WB and TH, and two extreme outliers at the LS. Examination 
revealed no clear reason for their departure from predictions; they were excluded from 
analysis. In the PRO group, 12, 6 and 5 participants withdrew from the intervention at 4, 8 
and 12 mo; in the CARB group, 14, 14 and 7 participants withdrew.  
Participants lost body weight, mean (95% CI) of 8.2% (7.5-8.9) at 4 mo and 10.5% 
(8.9-12.0) at 12 mo (no differences between diets, P=0.64; Supplemental Table 2). By 4 mo, 
energy intake was centered approximately at prescribed levels, and protein and calcium 
intakes diverged according to diet as prescribed (diet x time interaction P<0.05; Table 2). 
Energy intake did not differ by diet through the intervention (Table 2). At 4 mo protein 
intake was 1.37±0.04 g/(kg·d) or 29±0.6 percent of energy in the PRO group and 0.82±0.03 
g/(kg·d) or 18±0.3 percent of energy in the CARB group, indicating compliance to the 
prescribed dietary treatments. Protein intake at 12 mo was comparable (Table 2). By 12 mo 
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Fat intake was mildly increased compared to 4 mo irrespective of diet group (P<0.05) 
(Supplemental Table 2).  
As expected, increased protein in PRO participants replaced predominantly 
carbohydrate, although PRO participants also consumed slightly more fat (Supplemental 
Table 2). Calcium intake increased in the PRO group and declined in the CARB group with 
energy restriction (Table 2). PRO participants consumed (mean ± SEM) 387 ± 72 mg more 
calcium daily than CARB participants at 4 mo and 261 ± 81.6 at 12 mo (both P<0.01). While 
PRO calcium intakes met the RDA, calcium intake provided by the CARB diet was 
inadequate for female participants (Table 2). Because protein and calcium intakes increased 
or decreased together according to diet assignment, the ratio of protein:calcium intakes did 
not differ by diets or time (all P>0.05, Supplemental Table 2). Mean servings of dairy were 
as prescribed: 2 servings per day in CARB and 3 in PRO participants. Subjects reported no 
intake of supplements, as prescribed. Food records estimated PRO participants consumed 
169±16 IU vitamin D, 34±23 IU more than CARB participants (P=0.15); however our 
nutrient database was not complete for all foods with respect to vitamin D, and actual content 
may vary considerably from label values (18;19), making the accuracy of these estimates 
questionable. Physical activity was similar between groups (P>0.10). BMD at the WB, LS 
and TH was superior over the course of the study in PRO participants (Figure 1). BMC was 
also superior in PRO participants (P<0.05, Supplemental Table 3). 
Treatment differences were similar across gender and its two- and three-way 
interactions with diet and time for all bone outcomes (all P>0.05). Gender differences in 
BMD could be predicted by pre-intervention status, therefore gender effects were not 
significant after controlling for baseline values (P>0.10), indicating males and females were 
117 
similarly affected by the diets. Similarly, tests of age group (<40, 40-50, >50) and its 
interactions with diet and time in females were not significant, indirectly suggesting 
menopausal status did not moderate response. 
Urinary calcium declined by month 8 in the CARB group, but was maintained on the 
PRO diet (Figure 2). Adjusting for baseline BMC, diet group and gender, urinary calcium 
levels predicted decreased WB BMC (ß=-0.38, P=0.032), indicating that a portion of 
variation in urinary calcium that was not explained by protein intake was negatively 
associated with WB BMC. This effect was not observed for LS BMC (P=0.65) or TH BMC 
(P=0.59). 
Discussion 
After a combined 12 mo of weight loss (4 mo) and maintenance (8 mo), a weight loss 
diet prescribing 1.4 g/(kg·d) protein and 3 daily servings of dairy provided more calcium and 
preserved bone mineral relative to an isocaloric control diet prescribing 0.8 g/(kg·d) protein 
and 2 daily servings of dairy. Targeting lean protein sources including low fat dairy 
improved calcium intake in free-living individuals under reduced energy intake conditions, 
while a conventional, high carbohydrate diet provided inadequate calcium in females, 
consistent with other reports (20-21). These data indicate that a higher protein diet 
specifically emphasizing dairy preserves bone loss compared to an isoenergetic higher 
carbohydrate diet proportioned according to the Food Guide Pyramid. The present data do 
not permit the resolution of independent or interactive effects of protein and other dairy 
components such as calcium and vitamin D, but support the effectiveness of a high protein, 
high dairy diet for protecting bone health during weight loss in free living patients. 
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Shapses and Riedt (4) review reports of bone mineral loss with weight loss, and 
summarize that 10% weight loss would be expected to produce 1-2% bone loss at various 
sites. Loss of BMD with weight loss is thought to occur due to changes in the weight-bearing 
load. estrogen status, circulating leptin and reduced calcium intake with energy restriction. 
Skov et al. (8) reported that a higher protein diet conferred greater weight loss but similar 
bone loss, or an improved bone loss to weight loss ratio over 6 mo in adults. As in the present 
study, Skov et al. reported adequate calcium intakes on the higher protein diet, but low 
calcium intakes among higher carbohydrate dieters.  
The influence of protein intake on calcium balance and bone health remains 
controversial. Higher protein intakes consistently increase urinary calcium excretion (22). 
Early research found no connection between calcium absorption and protein intake (23-26), 
suggesting extra urinary calcium must reflect loss from bone (12). Specifically it is thought 
that bone is demineralized to buffer acid reabsorbed during renal handling of sulfate 
metabolites of dietary methionine and cysteine (27). More recently Kerstetter et al. (28-30) 
have reported increased calcium absorption with higher protein intakes using dual stable 
calcium isotopes and calcium- controlled interventions; however a similar study did not find 
elevated absorption based on protein intake (31). Roughead et al. (32) report no differences 
but a trend toward higher calcium retention in a group consuming increased protein from 
whole food (meat) sources. Critically, no differences in bone metabolism markers were 
observed. Another study demonstrated an increase in the fraction of urinary calcium of 
dietary origin during a diet providing 2.1 g/(kg·d) protein compared to a control diet 
providing 1.0 g/(kg·d) (13), suggesting additional excreted calcium did not originate in bone, 
but rather from improved intestinal absorption.  
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Dawson-Hughes et al. (33) reported a calcium, protein interaction in participants 
randomized to calcium supplementation or placebo and divided into tertiles of freely selected 
protein intake. Elderly participants consuming more protein and calcium gained bone mineral 
relative to those at lower intakes of either nutrient. Bowen, Noakes and Clifton (11) 
measured bone resorption and formation markers across 12 wk of weight loss on a mixed 
protein or dairy protein weight-loss diet, concluding that the calcium-rich, dairy based diet 
reduced bone turnover compared to a diet rich in protein but poorer in calcium. In the present 
study, ample calcium was supplied as a natural consequence of emphasizing lean protein 
sources, including dairy. 
Median daily urinary calcium was 167 mg for PRO and 98 mg for CARB dieters. On 
average, PRO males consumed approximately 400 mg and females 300 mg more calcium 
daily than CARB participants. Accordingly, assuming a conservative 20-25% calcium 
absorption, additional available calcium would approximately compensate or exceed urinary 
losses. We have no data to account for endogenous fecal calcium losses, which may also be 
influenced by protein intake (34), nor can we report actual calcium absorption. However if 
absorption increases with protein as reported by Kerstetter et al. (13; 28-30), gains in 
available calcium could substantially outweigh urinary losses, supporting bone 
mineralization. Our data support this speculation. 
Our study is not without limitations. Compliance assessment relies on 3 d weighed 
food records. Available nutrient databases are incomplete with respect to vitamin D, making 
inference concerning this nutrient difficult. DXA measurement is influenced by changes in 
tissue thickness, an effect that is not well quantified (35;36). Accordingly changes over time 
within diet groups should be interpreted with care; however the relative impact of the PRO 
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vs. CARB diet is interpretable, as groups did not differ in loss of weight, fat or body 
thickness. All measures demonstrated a marked benefit of the PRO compared to the CARB 
diet, on the order of 1 to 3%. The independent effects of increased protein and calcium on 
bone health are not known given the present design. Although limiting internal validity (i.e. 
isolation of protein and calcium effects), the design maximizes external validity, 
demonstrating that a high dairy, high protein diet will protect, not harm bone relative to a 
conventional weight loss diet in free living patients.  
In conclusion, a higher protein weight loss diet emphasizing dairy as a lean protein 
source naturally improved calcium intake and preserved bone mineral during weight loss 
relative to a conventional higher carbohydrate diet in this free living population. Though not 
observed in the present sample, it is likely that such a diet would improve vitamin D intake 
for some patients due to fortification of this nutrient in dairy, conferring further bone 
benefits. These data are consistent with current literature indicating dietary protein may have 
direct benefits to bone health, provided calcium intake is adequate (8-10;33). Obesity and 
osteoporosis are major public health concerns, and are at odds with one another: to treat the 
first is often inviting to the other. A dietary regimen that protects bone mineral while 
promoting fat loss is of high clinical value. 
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Chapter 6 Supplement: Additional details of statistical analysis 
 
 The mixed model approach provides more accurate confidence intervals in the face of 
study attrition compared to last value carried forward and list wise deletion approaches (37). 
An autoregressive (AR1) covariance structure was applied to the repeated measure, selected 
based on Schwarz's Bayesian Criterion from a number of commonly used structures. 
 Following the primary analysis, each model was re-tested covarying for calcium 
intake, with missing values imputed by the expectation maximization (EM) algorithm. 
Though linear mixed models perform well in analyses with missing data for dependent 
variables (37), missing values for covariates may introduce excessive variability into 
parameter estimates (38). Accordingly dietary calcium was tested as a covariate, with 
missing values (due to attrition) imputed using an expectation maximization (EM) procedure. 
For purposes of imputation calcium intake was normalized using a square root 
transformation. A single, influential outlier in the resulting, otherwise normal distribution 
was winsorized to the 99th percentile. In simulation studies the EM results in valid mean 
estimates but artificially narrow standard errors (39). This would increase the risk of an 
inappropriate finding of significance (a type I error); however in our analysis the calcium 
covariate was not a significant contributor to the model, precluding the possibility of a type I 
error. 
To test the assumptions of data missing at random (MAR) and missing completely at 
random (MCAR) (39), logistic regression was used to assess whether attrition at any of the 
three follow-up measurement periods could be predicted by bone outcome variables at the 
previous measurement period, independently or controlled for diet assignment, BMI, age, 
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gender and study site. Cox regression was also employed to determine whether attrition over 
the entire 12 mo course of the study could be predicted by group assignment, controlled for 
pre-study BMI, age, gender and study site. Cox regression indicated that the combination of 
diet [Exp(B)=0.57, P=0.043] and age [Exp(B)=0.95, P=0.001] predicted attrition, 
invalidating the MCAR assumption; however, logistic regression revealed no association 
between attrition and prior values of the dependent variable (all P>0.1), indicating data were 
MAR. 
 
 
123 
Chapter 6 References 
1. National Institutes of Health. Clinical guidelines on the identification, evaluation, and 
treatment of overweight and obesity in adults--the evidence report. Obes Res. 1998; 6 
Suppl 2:51S-209S. 
 
2. Jensen LB, Quaade F, Sorensen OH. Bone loss accompanying voluntary weight loss 
in obese humans. J Bone Miner Res. 1994; 9(4):459-463. 
 
3. Pritchard JE, Nowson CA, Wark JD. Bone loss accompanying diet-induced or 
exercise-induced weight loss: A randomised controlled study. Int J Obes Relat Metab 
Disord. 1996; 20(6):513-520. 
 
4. Shapses SA, Riedt CS. Bone, body weight, and weight reduction: What are the 
concerns? J Nutr. 2006; 136(6):1453-1456. 
 
5. Layman DK, Boileau RA, Erickson DJ, Painter JE, Shiue H, Sather C, Christou DD. 
A reduced ratio of dietary carbohydrate to protein improves body composition and 
blood lipid profiles during weight loss in adult women. J Nutr. 2003; 133(2):411-417. 
 
6. Farnsworth E, Luscombe ND, Noakes M, Wittert G, Argyiou E, Clifton PM. Effect of 
a high-protein, energy-restricted diet on body composition, glycemic control, and 
lipid concentrations in overweight and obese hyperinsulinemic men and women. Am 
J Clin Nutr. 2003; 78(1):31-39. 
 
7. Layman DK, Evans E, Baum JI, Seyler J, Erickson DJ, Boileau RA. Dietary protein 
and exercise have additive effects on body composition during weight loss in adult 
women. J Nutr. 2005; 135(8):1903-1910.  
 
8. Skov AR, Haulrik N, Toubro S, Molgaard C, Astrup A. Effect of protein intake on 
bone mineralization during weight loss: A 6-month trial. Obes Res. 2002; 10(6):432-
438. 
 
9. Alexy U, Remer T, Manz F, Neu CM, Schoenau E. Long-term protein intake and 
dietary potential renal acid load are associated with bone modeling and remodeling at 
the proximal radius in healthy children. Am J Clin Nutr. 2005; 82(5):1107-1114. 
 
10. Dawson-Hughes B, Harris SS, Rasmussen H, Song L, Dallal GE. Effect of dietary 
protein supplements on calcium excretion in healthy older men and women. J Clin 
Endocrinol Metab. 2004; 89(3):1169-1173. 
 
11. Bowen J, Noakes M, Clifton PM. A high dairy protein, high-calcium diet minimizes 
bone turnover in overweight adults during weight loss. J Nutr. 2004; 134(3):568-573. 
 
12. Barzel US, Massey LK. Excess dietary protein can adversely affect bone. J Nutr. 
1998; 128(6):1051-1053. 
124 
 
13. Kerstetter JE, O'Brien KO, Caseria DM, Wall DE, Insogna KL. The impact of dietary 
protein on calcium absorption and kinetic measures of bone turnover in women. J 
Clin Endocrinol Metab. 2005; 90(1):26-31. 
 
14. Dawson-Hughes B. Interaction of dietary calcium and protein in bone health in 
humans. J Nutr. 2003; 133(3):852S-854S. 
 
15. U.S. Department of Agriculture, Department of Health and Human Services. Dietary 
Guidelines for Americans. 4th ed. Washington, DC: DHHS, 1995. 
 
16. Food and Nutrition Board, National Research Council. Recommended Dietary 
Allowances. Washington, DC: National Academy Press, 1989. 
 
17. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman 
JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, et al. AHA dietary guidelines: 
Revision 2000: A statement for healthcare professionals from the nutrition committee 
of the american heart association. Circulation. 2000; 102(18):2284-2299. 
 
18.  Holick MF, Shao Q, Liu WW, Chen TC. The vitamin D content of fortified milk and 
infant formula. N Engl J Med. 1992;326:1178-1181. 
 
19. Murphy SC, Whited LJ, Rosenberry LC, Hammond BH, Bandler DK, Boor KF. Fluid 
milk vitamin fortification compliance in New York State. J Dairy Sci. 2001;84:2813-
2820. 
 
20. Benezra LM, Nieman DC, Nieman CM, Melby C, Cureton K, Schmidt D, Howley 
ET, Costello C, Hill JO, Mault JR, et al. Intakes of most nutrients remain at 
acceptable levels during a weight management program using the food exchange 
system. J Am Diet Assoc. 2001; 101(5):554-561. 
 
21. Melanson KJ, Angelopoulos TJ, Nguyen VT, Martini M, Zukley L, Lowndes J, Dube 
TJ, Fiutem JJ, Yount BW, Rippe JM. Consumption of whole-grain cereals during 
weight loss: Effects on dietary quality, dietary fiber, magnesium, vitamin B-6, and 
obesity. J Am Diet Assoc. 2006; 106(9):1380-8; quiz 1389-90. 
 
22. Kerstetter JE, O'Brien KO, Insogna KL. Low protein intake: The impact on calcium 
and bone homeostasis in humans. J Nutr. 2003; 133(3):855S-861S. 
 
23. Walker RM, Linkswiler HM. Calcium retention in the adult human male as affected 
by protein intake. J Nutr. 1972; 102(10):1297-1302. 
 
24. Allen LH, Oddoye EA, Margen S. Protein-induced hypercalciuria: A longer term 
study. Am J Clin Nutr. 1979; 32(4):741-749. 
 
125 
25. Hegsted M, Linkswiler HM. Long-term effects of level of protein intake on calcium 
metabolism in young adult women. J Nutr. 1981; 111(2):244-251. 
 
26. Spencer H, Kramer L, DeBartolo M, Norris C, Osis D. Further studies of the effect of 
a high protein diet as meat on calcium metabolism. Am J Clin Nutr. 1983; 37(6):924-
929. 
 
27. Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J 
Am Diet Assoc. 1995; 95(7):791-797. 
 
28. Kerstetter JE, Caseria DM, Mitnick ME, Ellison AF, Gay LF, Liskov TA, Carpenter 
TO, Insogna KL. Increased circulating concentrations of parathyroid hormone in 
healthy, young women consuming a protein-restricted diet. Am J Clin Nutr. 1997; 
66(5):1188-96. 
 
29. Kerstetter JE, O'Brien KO, Insogna KL. Dietary protein affects intestinal calcium 
absorption. Am J Clin Nutr. 1998; 68(4):859-865. 
 
30. Kerstetter JE, Svastisalee CM, Caseria DM, Mitnick ME, Insogna KL. A threshold 
for low-protein-diet-induced elevations in parathyroid hormone. Am J Clin Nutr. 
2000; 72(1):168-173. 
 
31. Heaney RP. Dietary protein and phosphorus do not affect calcium absorption. Am J 
Clin Nutr. 2000; 72(3):758-761. 
 
32. Roughead ZK, Johnson LK, Lykken GI, Hunt JR. Controlled high meat diets do not 
affect calcium retention or indices of bone status in healthy postmenopausal women. J 
Nutr. 2003; 133: 1020-1026. 
 
33. Dawson-Hughes B, Harris SS. Calcium intake influences the association of protein 
intake with rates of bone loss in elderly men and women. Am J Clin Nutr. 2002; 
75(4):773-779. 
 
34. Davies KM, Rafferty K, Heaney RP. Determinants of endogenous calcium entry into 
the gut. Am J Clin Nutr. 2004; 80(4):919-923. 
 
35. Evans EM, Mojtahedi MC, Kessinger RB, Misic MM. Simulated change in body 
fatness affects hologic QDR 4500A whole body and central DXA bone measures. J 
Clin Densitom. 2006; 9(3):315-322. 
 
36.  Tothill P. Dual-energy x-ray absorptiometry measurements of total-body bone 
mineral during weight change. J Clin Densitom. 2005; 8(1):31-38. 
 
37. Mallinckrodt CH, Clark WS, David SR. Accounting for dropout bias using mixed-
effects models. J Biopharm Stat. 2001; 11(1-2):9-21. 
 
126 
38. Schafer JL, Yucel RM. Computational strategies for multivariate linear mixed-effects 
models with missing values. Journal of Computational and Graphical Statistics. 2002; 
11(2):437-457. 
 
39. Allison PD. Missing Data. 07-136 ed. Thousand Oaks, CA: Sage, 2002. 
127 
Table 6.1. Baseline characteristics of adults randomized to a higher protein, dairy rich diet 
(PRO) or a conventional higher carbohydrate diet (CARB)1. 
  PRO CARB 
F 45 (35-51) 46 (41-52) Age, y 
M 46 (39-55) 48 (39-53) 
F 82.3 (77.6-86.5)a 85.8 (77.5-94.3)a Weight, 
kg M 94.5 (88.2-107) 98.1 (92.4-106) 
F 30.9 (28.7-34.2) 31.8 (29.6-35.0) BMI, 
kg/m² M 30.9 (29.0-34.4) 31.9 (29.9-35.0) 
F 1.13 (1.03-1.21)a,b 1.19 (1.12-1.22)a WB BMD, 
g/cm² M 1.26 (1.17-1.30) 1.20 (1.14-1.33) 
F 1.02 (0.89-1.13) 1.06 (0.99-1.14) LS BMD, 
g/cm² M 1.04 (0.94-1.13) 1.04 (0.98-1.11) 
F 0.95 (0.88-1.01)a 1.02 (0.94-1.06)a TH BMD, 
g/cm² M 1.07 (1.03-1.16) 1.05 (0.99-1.15) 
1 Values are median (inter quartile range). n= 64 (28 males) for PRO, 66 (31 males) for 
CARB. a Differs from males (P<0.05). b Differs from CARB (P<0.05). 
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Table 6.2. Dietary intakes in adults randomized to a higher protein, dairy rich diet (PRO) or 
a conventional higher carbohydrate diet (CARB) during weight loss (baseline to 4 mo) and 
weight maintenance (4 mo to 12 mo) periods 1. 
   Baseline 4 mo 12 mo 
PRO 8.5 (7.7-9.4) 5.9 (5.6-6.6)a 6.1 (5.6-6.9)a F 
CARB 8.5 (7.5-9.8) 5.9 (5.3-7.1)a 6.3 (5.5-7.0)a 
PRO 11 (9.5-13)b 7.3 (6.0-8.4)a 8.0 (7.1-8.8)a 
Energy, 
MJ/d 
M 
CARB 7.9 (6.7-9.3) 6.9 (5.9-7.5)a 7.5 (6.5-9.5) 
PRO 79 (66-90) 97 (88-114)a,b 99 (87-116)a,b F 
CARB 76 (68-88) 61 (58-75)a 60 (57-69)a 
PRO 101(94-124)b 125 (118-149)b 128 (106-155)a,b 
Protein,  
g/d 
M 
CARB 82 (74-93) 74 (63-82) 74 (68-87) 
PRO 0.76 (0.62-1.07) 1.05 (0.82-1.33)a,b 1.00 (0.82-1.21)b F 
CARB 0.89 (0.65-1.15) 0.73 (0.62-0.90) 0.69 (0.63-0.92) 
PRO 0.93 (0.79-1.23) 1.19 (0.91-1.53)b 1.26 (0.83-1.38) 
Calcium,  
g/d 
M 
CARB 0.72 (0.61-1.16) 0.80 (0.56-1.00) 1.00 (0.67-1.15) 
1 Values are median (inter quartile range), total n=130. a differs from baseline (P<0.05). b 
differs from CARB diet within time and gender (P<0.05). 
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Supplemental Table 6.1. Pre-intervention bone mineral content (BMC) of the whole body 
(WB), lumbar spine (LS) and total hip (TH) 1. 
  PRO diet CARB diet 
Fa 2189±58.5 2318±43.6 WB BMC, 
g M 2851±67.3 2891±73.0 
Fa 57.1±2.04 60.5±1.67 LS BMC, 
g M 69.8±2.03 71.8±2.04 
Fa 31.3±0.98 32.1±0.82 TH BMC, 
g M 45.2±1.30 46.5±1.49 
1 Values are mean ± SEM. n=130. a Differs from males (P<0.05). Diet main effect and 
interaction of diet x sex were not significant (P>0.05). 
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Supplemental Table 6.2. Additional intakes in adults randomized to a higher protein, dairy 
rich diet (PRO) or a conventional higher carbohydrate diet (CARB) during weight loss 
(baseline to 4 mo) and weight maintenance (4 mo to 12 mo) periods 1. 
   Baseline 4 mo 12 mo 
PRO 268 (226-303) 147 (129-168)a,b 147 (133-156)a,b F 
CARB 267 (213-289) 200 (184-249)a 203 (179-232)a 
PRO 319 (244-371)b 155 (130-203)a,b 179 (144-216)a,b 
Carb,  
g/d 
M 
CARB 237 (211-265) 227 (208-279) 274 (199-341) 
PRO 79 (63-90) 51 (46-57)a 59 (49-67)a F 
CARB 75 (65-87) 45 (32-57)a 47 (39-61)a 
PRO 100 (73-154)b 63 (50-83)a,b 76 (66-88)a 
Fat,  
g/d 
M 
CARB 69 (57-85) 38 (30-49)a 58 (37-71) 
F PRO 96 (73-118) 98 (84-111) 103 (89-113) 
 CARB 83 (74-99) 89 (78-99) 89 (70-97) 
M PRO 109 (90-124) 104 (91-120) 116 (101-134) 
Protein: 
calcium 
ratio 
 CARB 108 (80-129) 93 (76-128) 75 (69-106) 
1 Values are median (inter quartile range), total n=130. a differs from baseline (P<0.05). b 
differs from CARB diet within time and gender (P<0.05). 
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Supplemental Table 6.3. Bone mineral content (BMC) of the whole body (WB), lumbar 
spine (LS) and total hip (TH) after 4, 8 and 12 mo of a randomly assigned high protein, high 
dairy, high calcium (PRO) or conventional high carbohydrate (CARB) diet 1. 
    4 mo   8 mo   12 mo 
PRO 2539±8.5 2522±9 2560±9.4 
CARB 2524±8.6 2500±9.4 2502±10.3 
WB 
BMC, 
g P Diet x time: <0.01a  
PRO 66.16±0.35 66.62±0.37 66.57±0.39 
CARB 65.58±0.34 65.23±0.38 65±0.42 
LS 
BMC, 
g P Diet: <0.01 Time: 0.89  
PRO 38.14±0.19 38.04±0.2 37.92±0.21 
CARB 37.77±0.19 37.86±0.21 37.07±0.23 
TH 
BMC, 
g P Diet: 0.04 Time: 0.01  
1 Estimated marginal means ± SEM, adjusted for baseline BMC, gender, study site and two- 
and three-way interactions of site and gender with diet and time. Only the interaction of diet 
x time for WB BMC wassignificant (all other P>0.05). Total n=130. a Post hoc tests revealed 
differences at 12 mo (P<0.01), but not 8 (P=0.08) or 4 (P=0.19) mo (12 mo difference robust 
to a Bonferroni adjustment for multiple comparisons).
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Figure 6.1.  Bone mineral density (BMD) during at 4, 8 and 12 mo weight of a high protein, 
dairy and calcium diet (PRO, ○) or a conventional higher carbohydrate diet (CARB, ●) in 
adults. A: whole body (WB), B: lumbar Spine (LS) and C: total hip (TH). Values adjusted for 
baseline BMD using a linear mixed model with random slopes, n=130. No significant two- or 
three-way interactions of gender or site of participation with time and diet were detected (all 
P>0.05).  
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Figure 6.2. Urinary calcium excretion (mean ± SEM) at baseline and 8 mo of a high protein, 
high dairy, high calcium diet (PRO, ○) compared to a conventional higher carbohydrate 
(CARB, ●) diet in adults. Values tested using ANCOVA adjusted for baseline urinary 
calcium excretion, n=40. 
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Chapter 7 
Conclusion 
 
Summary of Chapters 
 The relationship between protein intake and bone health has been elusive over many 
decades of investigation. An emerging view of this complex association proposes that protein 
may have both positive and negative effects, depending on other considerations of the diet 
(1-4). Although this theoretical model aptly explains the available data, the model has not 
been formally tested using statistical models that quantify both positive and negative 
pathways. In the studies presented herein, the application of mediational modeling provides 
quantitative support for the theory, and casts light on some of the mechanisms determining 
whether protein’s influence is positive, negative or null.  
In a cross sectional investigation in postmenopausal women, protein improved BMD 
after adjusting for a negative effect of the sulfur containing amino acids thought to be 
responsible for damaging effects of protein. In rats, a similar picture emerged, with positive 
effects of protein mediated by IGF-1 counterbalanced by negative effects of some 
unmeasured pathway. A second rat study illustrates that protein sources may improve or 
decrease bone strength, and that these effects are mediated by changes in body composition, 
especially lean body mass.  
During weight loss, the combination of higher protein intake and additional calcium 
protected adult men and women from the bone loss normally associated with energy 
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restriction. It is uncertain whether those effects are attributable to protein, calcium or their 
interaction; however, a mathematical model of bone mass change and urine calcium in this 
sample suggests that changes in dietary calcium were insufficient to account for 
improvements (Appendix A). Furthermore urine calcium, an index of the diet acid load, was 
negatively associated with bone density in spite of being elevated in the higher protein diet. 
This counterintuitive result is difficult to test in mediational modeling due to the 
experimental design, but is consistent again with the notion that protein concurrently 
stimulates negative, acid-mediated and positive changes in bone. 
 These data are consistent with a review of the literature that protein can improve or 
deteriorate bone health, with no strong effect observed on average (5). The purported benefits 
and harms are small, and unlikely to be of great clinical consequence, though they may be 
important on the scale of public health. Certainly these data refute persistent arguments 
against higher protein diets on the grounds of theoretical harms to bone, as a true negative 
effect of the protein induced acid load is likely to be offset by benefits of protein to calcium 
absorption and/or the IGF-1 axis. 
Causal Inference 
 In 1965 A.B. Hill (6) proposed a system of criteria that is still the most influential 
system of criteria for determining causation today. These criteria are summarized in Table 
7.1. Hill never proposed that all criteria must be fulfilled in order to conclude that a 
relationship is causal rather than spurious. On the contrary he suggests that although all 
criteria are important to consider, very strong evidence within any one criterion is adequate 
to support a causal relationship and spur appropriate public health action. By way of 
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example, while no long term, randomized, controlled trials are available to establish that 
smoking causes lung cancer, this causal relationship is hardly challenged in light of strong 
evidence of a strong relationship, a dose response pattern, a temporal dependence and a 
consistency of the association across variable populations. I propose that the balance of 
evidence, when weighed against Hill’s criteria, support a dual pathway model of protein and 
bone health. 
Strength 
 The defended research has consistently shown a statistically significant effect of 
protein on bone after accounting for one of the proposed mediating effects. These effects, 
however, have been small, and the overall average effect of higher protein intakes on bone is 
close to zero (5). Accordingly, the criterion of strength is consistent with a causal 
relationship, but insufficient by itself to rule out a spurious association. 
Consistency 
 The consistency of support for the dual pathway model across population, animal and 
clinical studies is striking, and is perhaps the strongest support for a causal relationship. 
Across multiple studies and especially different research paradigms, we expect measurement 
and sampling error to “average out,” allowing pure relationships to surface over repeated 
investigation. Extending beyond the data defended herein, a dual pathway model has also 
been consistent across gender and age, from youth (7) to older men and women (8), in studies 
which have experimentally or statistically isolated the effects of the diet acid load from those 
of protein or its interaction with calcium. Although additional replication is necessary to 
evaluate the relative importance of various proposed mediators of the protein bone 
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relationship, I propose the auspicious consistency of support for the dual pathway model 
provides strong evidence for a true causal relationship. 
Specificity 
 In contrast, the criterion of specificity or a one-to-one relationship seems to be the 
most limiting, and its absence is arguably the cause of so many years of controversy 
surrounding the protein-bone question. While the feeding of alternate acid sources has 
produced predictable changes in calcium balance and bone tissue, there is no reliable one-to-
one connection between a high protein diet and osteoporosis or bone fracture. In fact, by its 
very nature the dual pathways model is incompatible with a specific relationship, since many 
mediators are proposed to compete to produce any of beneficial, harmful or absent outcomes. 
Because of this complexity, it may be argued that the model explains the conflicted literature 
simply because it allows for essentially any result to be accepted as supporting. While not 
damning, the lack of specificity increases the demand on the theory to satisfy other criteria. 
In particular, the lack of specificity must be reconciled by legitimate biological mechanisms 
that would allow for the observed complexity. 
Plausibility (mechanism) 
 Although mechanisms for the proposed positive and negative pathways are not fully 
understood, several specific mediators have been proposed and found to statistically explain 
some part of the relationship between protein and bone. It is known that protein imposes a 
dietary acid load (9), and that a dietary acid load from other sources causes damage to bone 
(10-13). In contrast, it is probable that IGF-1 (14-16), calcium absorption (17; 18) and lean 
body mass (19; 20) are both improved by protein intake and can improve bone health in turn. 
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Further work along each of these lines of inquiry is needed to clarify the optimal diet for 
bone health, but the theoretical plausibility and replication of each of these pathways appears 
sufficient to meet the burden of plausibility mandated by the non-specific relationship 
between protein and bone. 
Coherence 
 Hill notes that plausibility cannot always be strictly required, as observational 
relationships may be apparent before science has discovered plausible biological mechanism. 
In the absence of plausibility, coherence demands that the proposed relationship at least not 
be in conflict with current knowledge. It has been argued that coherence for the negative, 
acid-load mediated pathway is not satisfied, because dietary manipulations of acid-base 
balance are unlikely to produce a noticeable impact on the pH of the bone interstitial fluid 
(21). Pizzorno (22) has taken care to discriminate acidemia, a change in the pH of the blood, 
from acidosis, a change in active acid-base regulatory systems, including buffer 
concentrations. Although acidemia is indeed only slightly inducible by diet (23-25), subtle 
changes to acid base balance may have profound effects on the regulation of bone cells (26), 
particularly if the bone interstitial fluid immediately adjacent to cells is near pH 7.1, as has 
been shown for skin (27). The regulation of bone cells in vivo in response to realistic acid 
loads is not determined, but at this time it appears both plausible and coherent that a diet acid 
load induces subtle but chronic adverse changes in bone.   
Analogy 
Hill discusses analogy again primarily in the context of an absent plausible 
mechanism. That is, where the physiological connection is unknown, can it at least be said to 
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be similar to some known causal relationship. In the present case, it is useful to draw analogy 
between the influence of dietary protein and alternate dietary sources of fixed acid. 
Supplementation of various non-protein acid sources, including isolated sulfur amino acids, 
unambiguously cause damage to bone in animal models (10-13). In contrast, fixed alkali 
supplements are beneficial in humans (28-31). That no consistent effect of a similar acid load 
from complete protein sources exists is striking, and can only be explained in one of two 
ways. 1) The acid load of protein is unique from other acid sources, and does not evoke the 
harmful response observed with other acid sources. 2) The acid load of protein exerts its 
expected adverse effect, but is opposed by alternate, beneficial pathways. The first option is 
unlikely given that sulfur amino acids do exert a negative effect independent of total protein 
(4; 10). The second option is supported by analogy to the reported benefits of IGF-1, calcium 
absorption and lean body mass. 
Temporality 
 The animal and clinical work herein establishes the requisite temporal relationship for 
causal inference. Changes in the protein amount or source, the proposed cause, precede 
changes in bone outcomes, the proposed effect. This does not rule out the possibility of some 
time-varying confounder. For example in the clinical trial, it is possible that the improvement 
in bone outcomes is attributable to improved calcium intake accompanying increased dietary 
protein. Appendix A addresses this question through a mathematical model, suggesting that 
the difference in bone mass change between diets is too large to be explained by measured 
calcium intakes alone. This conclusion depends heavily on the reliability of urine and dietary 
calcium measures, which is tenuous, but the probable effects of bias and error in these 
measures would be to mask a true difference between diet groups, rather than creating a 
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spurious one. Furthermore, the highly controlled experimental conditions in the two animal 
studies aptly undermine the possibility of time varying confounders.  
Dose-response 
 Not every causal relationship involves a dose-response relationship. Threshold 
effects, J-shaped curves and interactions are examples of causal relationships that may 
produce apparently non-linear effects, and are each ubiquitous in nutrition. In the present 
case, however, we have consistently observed a linear relation between bone outcomes and 
IGF-1, lean body mass or the sulfur amino acid load, and a corresponding effect of total 
protein intake that is approximately equal in magnitude but opposite in direction. This unique 
pattern of statistical suppression (32) seems to provide strong support for the dual-pathway 
model, since it is difficult to conceive a confounding variable that might explain the observed 
opposing relationship across multiple mediators and research paradigms. 
Experiment 
 As alluded to under temporality, the experimental support for the dual pathways 
model provided herein lends strong support. In each case, proposed mediators were not 
randomly assigned but allowed to vary naturally in response to manipulations of dietary 
protein. Although this permits the theoretical possibility of a time-varying confounder, the 
tight control of experimental conditions within animal studies makes this considerably less 
probable. Furthermore, a test of statistical mediation must necessarily consider the effect of 
protein on the proposed mediator, as well as the effect of the mediator on the outcome. That a 
pattern of dual, mediated pathways emerged in these experimental protocols all but rules out 
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the possibility that some extraneous factor explains the observed positive and negative 
effects. 
Limitations 
 These studies have not addressed vitamin D except in ruling it out as a confounder 
through experimental or statistical control. Due to these controls, it is probable that the 
proposed mediation of protein’s influence on bone operates independently of vitamin D on 
average. These relationship have not, however, been tested over a considerable range of 
vitamin D status, therefore we cannot rule out that vitamin D may modify these associations. 
 Similarly, data presented herein almost invariably involve sedentary to low amounts 
of physical activity. It is reasonable to expect that exercise might modify these relationships, 
by increasing the protein requirement, by potentiating the increase in lean body mass with 
protein, by regulation of normal acid base physiology or by providing direct stimulation of 
bone growth that could potentially either enhance or obviate any influence of protein. 
 Also, the role of IGF binding proteins have not been tested, though they are both 
relevant to bone physiology (33) and regulated by protein in the diet (14; 34). It is possible 
that some part of the mediational role of IGF-1 is itself mediated or potentiated by nutritional 
regulation of its binding proteins. 
 Along the same line, the mediational models tested have relied on one global 
indicator of more complex individual pathways. The regulation of bone by dietary acid load 
is not completely understood in vivo, nor is the influence of IGF-1. While these results 
support the theoretical dual pathway model, they are not themselves mechanistic studies. 
These data therefore are best interpreted as identifying relevant pathways connecting protein 
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intake to bone and estimating reasonable effect sizes, rather than elucidating any particular  
pathway. 
Future Directions 
 These data highlight the importance of sulfur amino acids, IGF-1, calcium availability 
and lean body mass as mediators the effect of protein on bone. The application of mediation 
models has allowed these relationships to be quantified. However in each investigation, only 
one mediator was specifically accounted for. It would be important from a public health 
perspective to evaluate which if any of these specific pathways predominates in a large 
sample of free-living humans. Measurement of calcium absorption is difficult and not 
feasible in large samples, however other pathways may be testable using secondary analysis 
of existing large data sets such as NHANES or Health ABC at low cost. 
 It is unclear how dietary protein influences calcium absorption. Regulation of the 
calcium Sensing Receptor is an emerging possibility, however the importance of this 
mechanism at physiological intakes has not been established. Similarly, while well defined 
acid-base regulatory pathways in bone are emerging  in vitro, the importance of these 
pathways in response to realistic diet acid loads has not been tested. This would be difficult 
to test non-invasively, but gene expression studies in animal models may shed light. It is also 
important to establish whether the interstitial pH experienced by bone cells is indeed lower 
than the generally buffered set point of 7.4, as has been shown in skin. 
 The role of protein source in calcium balance and longer term bone health has not 
been well characterized. In epidemiology, assessment of particular key amino acids rather 
than blunt food groups or total protein intake would be beneficial. In clinical trials, differing 
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protein sources have been tested, but sample sizes have not been adequate to control type II 
error.  
Perhaps most importantly, the specific predictions of the dual pathways model should 
be tested explicitly. Again, secondary use of large data sets may be most useful in comparing 
the relationship of protein with bone density at different levels of overall dietary acid load. 
Since the current evidence suggests any benefits are probably small, it would be prudent to 
continue clarifying these relationships through these lower cost approaches. The expense of 
long term randomized trials is probably not justified unless preliminary evidence indicates 
the benefit of some particular combination of protein source, calcium and fixed alkali is large 
enough to be clinically important. 
Summary 
 I have defended the position that protein causes both positive and negative changes in 
bone. In terms of Hill’s criteria for causal inference (Table 7.1), these effects are apparently 
weak though statistically significant, and are remarkably consistent across populations and 
research approaches. This dual pathway model by its nature does not describe a specific, one-
cause to one-disease relationship, making causal inference increasingly dependent on valid 
biological mechanism and coherence with existing knowledge. The work of other authors 
providing the required plausible mechanism has been reviewed. The relationship is coherent 
with and analogous to other research establishing the negative influence of a diet acid load 
and the positive influences of IGF-1, of calcium absorption and of lean body mass. The 
temporal and apparently linear dose-response relationships observed in these data, as well as 
the support from well controlled animal models provide a sound basis for ruling out 
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confounding in these studies. Accordingly, on the whole, I propose that Hill’s criteria are 
aptly met, and it is reasonable to conclude at this time that protein indeed causes positive and 
negative changes in bone. 
 On average, these effects are roughly equal in magnitude and opposite in direction, 
suggesting that in free living individuals any net influence of protein is likely to be modest or 
absent. If correct, the dual pathway model I have defended would predict that a higher 
protein diet, in the context of ample calcium and alkalizing fruits and vegetables, may 
provide modest benefits to bone.   
145 
Chapter 7 References 
1. Tucker KL, Hannan MT, Kiel DP. The acid-base hypothesis: diet and bone in the 
Framingham Osteoporosis study. Eur J Nutr 2001;40(5):231-237. 
 
2. Dawson-Hughes B. Interaction of dietary calcium and protein in bone health in humans. 
J Nutr 2003;133(3):852S-854S. 
 
3. Sebastian A. Dietary protein content and the diet's net acid load: opposing effects on 
bone health. Am J Clin Nutr 2005;82(5):921-922. 
 
4. Thorpe M, Mojtahedi MC, Chapman-Novakofski K, McAuley E, Evans EM. A positive 
association of lumbar spine bone mineral density with dietary protein is suppressed by a 
negative association with protein sulfur. J Nutr 2008;138(1):80-85. 
 
5. Darling AL, Millward DJ, Torgerson DJ, Hewitt CE, Lanham-New SA. Dietary protein 
and bone health: a systematic review and meta-analysis. Am J Clin Nutr 
2009;90(6):1674-1692. 
 
6. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 
1965;58(5):295–300. 
 
7. Alexy U, Remer T, Manz F, Neu CM, Schoenau E. Long-term protein intake and dietary 
potential renal acid load are associated with bone modeling and remodeling at the 
proximal radius in healthy children. Am J Clin Nutr 2005;82(5):1107-1114. 
 
8. Dawson-Hughes B, Harris SS. Calcium intake influences the association of protein 
intake with rates of bone loss in elderly men and women. Am J Clin Nutr 
2002;75(4):773-779. 
 
9. Frassetto L, Todd K, Morris R, Sebastian A. Estimation of net endogenous noncarbonic 
acid production in humans from diet potassium and protein contents. Am J Clin Nutr 
1998;68(3):576-583. 
 
10. Whiting SJ, Draper HH. Effect of a chronic acid load as sulfate or sulfur amino acids on 
bone metabolism in adult rats. J Nutr 1981;111(10):1721-1726. 
 
11. Bushinsky DA. Acid-base imbalance and the skeleton. Eur J Nutr 2001;40(5):238-244. 
 
12. Barzel U. Acid-induced osteoporosis: an experimental model of human osteoporosis. 
Calcif Tissue Int 1975;21(1):417-422. 
 
13. Macleay JM, Olson JD, Turner AS. Effect of dietary-induced metabolic acidosis and 
ovariectomy on bone mineral density and markers of bone turnover. J Bone Miner Metab 
2004;22(6):561-568. 
 
146 
14. Noguchi T. Protein nutrition and insulin-like growth factor system. Br J Nutr 
2000;84(Suppl 2):S241-244. 
 
15. McCarthy TL, Centrella M, Canalis E. Insulin-like growth factor (IGF) and bone. 
Connect Tissue Res 1989;20(1-4):277-282. 
 
16. Dawson-Hughes B, Harris SS, Rasmussen H, Song L, Dallal GE. Effect of dietary 
protein supplements on calcium excretion in healthy older men and women. J Clin 
Endocrinol Metab 2004;89(3):1169-1173. 
 
17. Kerstetter JE, O'Brien K, Insogna K. Dietary protein and intestinal calcium absorption. 
Am J Clin Nutr 2001;73(5):990-991. 
 
18. Kerstetter JE, O'Brien KO, Caseria DM, Wall DE, Insogna KL. The impact of dietary 
protein on calcium absorption and kinetic measures of bone turnover in women. J Clin 
Endocrinol Metab 2005;90(1):26-31. 
 
19. Heaney RP, Layman DK. Amount and type of protein influences bone health. Am J Clin 
Nutr 2008;87(5):1567S-1570S. 
 
20. Frost HM. On our age-related bone loss: insights from a new paradigm. J Bone Miner 
Res 1997;12(10):1539-1546. 
 
21. Bonjour J. Dietary protein: an essential nutrient for bone health. J Am Coll Nutr 
2005;24(Suppl 6):526S-536. 
 
22. Pizzorno J, Frassetto LA, Katzinger J. Diet-induced acidosis: is it real and clinically 
relevant? Br J Nutr 2010;103(8):1185-1194. 
 
23. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. Effect of diet on plasma acid-
base composition in normal humans. Kidney Int 1983;24(5):670-680. 
 
24. Buclin T, Cosma M, Appenzeller M, Jacquet AF, Décosterd LA, Biollaz J, Burckhardt P. 
Diet acids and alkalis influence calcium retention in bone. Osteoporos Int 
2001;12(6):493-499. 
 
25. Konig D, Muser K, Dickhuth H, Berg A, Deibert P. Effect of a supplement rich in 
alkaline minerals on acid-base balance in humans. Nutr J 2009;8(1):23. 
 
26. Arnett TR. Extracellular ph regulates bone cell function. J Nutr 2008;138(2):415S-418. 
 
27. Martin GR, Jain RK. Noninvasive measurement of interstitial ph profiles in normal and 
neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res 
1994;54(21):5670-5674. 
 
 
147 
28. Wynn E, Krieg M, Aeschlimann J, Burckhardt P. Alkaline mineral water lowers bone 
resorption even in calcium sufficiency: alkaline mineral water and bone metabolism. 
Bone 2009;44(1):120-124. 
 
29. Sebastian A, Harris ST, Ottaway JH, Todd KM, Morris RC. Improved mineral balance 
and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. 
N Engl J Med 1994;330(25):1776-1781. 
 
30. Litzow JR, Lemann J, Lennon EJ. The effect of treatment of acidosis on calcium balance 
in patients with chronic azotemic renal disease. J Clin Invest 1967;46(2):280-286. 
 
31. Dawson-Hughes B, Harris SS, Palermo NJ, Castaneda-Sceppa C, Rasmussen HM, Dallal 
GE. Treatment with potassium bicarbonate lowers calcium excretion and bone resorption 
in older men and women. J Clin Endocrinol Metab 2009;94(1):96-102. 
 
32. MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding 
and suppression effect. Prev Sci 2000;1(4):173. 
 
33. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ. Studies on 
regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 
production in human bone cells. Acta Endocrinol 1992;127(6):555-564. 
 
34. Clemmons DR, Underwood LE. Nutritional regulation of IGF-I and IGF binding 
proteins. Annu Rev Nutr 1991;11:393-412. 
 
148 
149 
Table 7.1. Hill’s criteria for causal inference. 
Strength 
Coherence 
(theoretical 
consistency) 
Temporality 
Consistency Experiment Dose Response 
Specificity          
(1 to 1) 
Analogy 
Biological 
Plausibility 
 
Appendix A 
Dietary calcium may be more bioavailable using a weight loss diet  
that replaces moderate amounts of carbohydrate with protein 
 
Weight loss causes bone mineral loss. We previously reported subjects prescribed 1.6 
g/kg·d of dietary protein (PRO) consumed more dairy, excreted more calcium in urine and 
preserved bone mineral relative to controls consuming 0.8 g/kg·d (CARB) during weight 
loss. It is unclear whether attenuation of bone mineral loss was related to increases in calcium 
intake, availability or both. 
We modeled calcium balance over 120 d for 41 adult males and females (47±7 y) 
randomized to PRO or CARB diets using 3 d weighed food records of calcium intake, 24 h 
urinary calcium (UCa) and DXA-estimated whole body bone mineral content (BMC) as a 
proxy for total bone calcium. We defined availability as the fraction of calcium intake 
explaining changes in bone mineral mass, after accounting for urinary calcium losses; this 
included unmeasured parameters absorbed calcium and endogenous intestinal calcium loss 
(Figure 1): 
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −=
CaDiet
CaFecalEndogenous
CaDiet
CaAbsorbed
tyAvailabili   eq.1  
Non-bone internal calcium pools were assumed constant. Availability was solved for each 
subject given: 
     eq. 2 ∑
=
−⋅Δ
120
1
)()(~
d
dd UCatyavailabiliCaBMC
Estimates of calcium availability were higher by 22.0% (95% CI: 0.2, 43.8) in PRO 
vs. CARB (Figure 2) suggesting BMC change cannot be completely accounted for by 
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increased calcium intake with a higher protein diet; however, whether benefits to BMC are 
related to increased calcium absorption, reduced endogenous intestinal calcium loss or a 
combination is unclear. 
 
Figure A.1. BMC, dietary Ca and urine Ca were measured. Availability was approximated 
by estimating change in BMC as the product of dietary calcium and availability, minus 
urinary calcium loss. 
 
 
Figure A.2. Estimated availability is improved in PRO compared to CARB participants. 
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Appendix B 
Instrumental variable analysis to adjust for non-compliance  
to randomized dietary interventions 
 
Abstract 
Non-compliance in randomized controlled trials (RCT) dilutes estimated treatment 
efficacy under intent-to-treat analysis (ITT), producing an overly conservative statistic. 
Another approach, instrumental variable (IV) analysis, uses measurements of compliance or 
dose received to estimate the treatment effect in compliant patients. The approach has gained 
acceptance in clinical trial methodology but is not commonly applied to dietary interventions. 
We use a RCT investigating the role of dietary protein on bone health, under weight loss 
conditions, to explore benefits and limitations of IV analysis.  Patients (n=62) were 
randomized to weight loss diets providing 1.4 (PRO) or 0.8 (CHO) g/kg•d protein. 
Compliance was measured using weekly 3d weighed food records. Change in total hip bone 
mineral density (BMD) as a percent of baseline, measured by dual X-ray absorptiometry, was 
compared at 1 y. IV analysis was applied using two-stage least squares regression.  
Based on ITT analysis, random assignment to PRO (without respect to compliance) 
caused a (standardized B±SE) 0.35 ± 0.12 (p=0.005) improvement in BMD compared to 
CHO. IV analysis estimated this value at 0.47 ± 0.18 (p=0.009). Accounting for non-
compliance using an IV approach resulted in a 33% increase in estimated efficacy of 
treatment. IV analysis may provide unbiased estimates of efficacy, corrected for 
noncompliance, in the interpretation of RCTs. The paper presents a discussion of logic and 
implementation of IV analysis. 
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Introduction 
 Noncompliance is a pervasive problem in human clinical trials. In its most benign 
presentation, noncompliance is random, or uncorrelated with treatment assignment and 
outcome. Such noncompliance is said to be ignorable, as it does not confound the estimated 
treatment effect. However, in its more pernicious and perhaps more frequent presentation, 
noncompliance is correlated with other patient characteristics, with repercussions on the 
outcome of interest. These associations can introduce confounding into the experiment, 
destroying the primary advantage of the randomized, controlled trials (RCTs). Even 
“ignorable” noncompliance dilutes differences in outcome between treatment groups under 
intent-to-treat (ITT) analysis, potentially obscuring physiologic effects. 
 This paper reviews the problem of noncompliance, the traditional ITT estimate of 
treatment effect, and an alternate approach, instrumental variable (IV) analysis, to 
statistically adjust for bias introduced by noncompliance. It is not meant as a technical 
statistical description, but instead emphasizes the logic and practical considerations of 
dealing with noncompliance. IV analysis was developed decades ago in the field of 
economics, and has since become established in observational epidemiology (1). The unique 
design of RCTs provides special advantages to the use of IV analysis (2; 3), but the IV 
approach is still rarely applied to RCTs and has not yet, to the authors’ knowledge, been 
applied to RCTs of nutritional interventions. The method requires careful measurement and 
evaluation of noncompliance patterns and provides further insight into the physiologic effect 
of a dietary intervention. An example will be drawn from real data regarding the impact of a 
higher protein, weight loss diet on bone density. 
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The rationale for randomization: Preventing confounding 
Randomized, controlled trials (RCT) are accepted as the gold standard for 
establishing causal effects of a treatment on an outcome of interest. Specifically, 
randomization is intended to prevent confounding influences from introducing bias into 
estimates of a treatment effect. The logic of confounding is familiar, and is depicted in Figure 
1. If all confounders are accurately measured and included in the model, we can obtain an 
accurate estimate of the causal effect of x on y: 
εβββ +++= wxy 0      eq. 1 
where ß0 reflects the intercept, ßx and ßw the effects of treatment x and confounders w on y, 
and ε the error. 
In practice however we are never privy to all confounding influences. As a result, our 
estimate of the effect of x on y, without knowledge of w, is biased by a function of ßw (the 
association of w and y) and the correlation ρ between x and w (4):  
εσ
σρβββ +++= xy
x
w
xwwx )(0      eq. 2 
Confounding, then, describes the treatment effect ßx being ‘muddied’ by the portion of the 
unmeasured variable w that is correlated with both x and y.  
  Randomization offers a straightforward solution to the problem of confounding. By 
allowing x to be determined by random chance, we have ensured that the correlation ρxw is 
approximately zero, and so equation 1 reduces to: 
εββ ++= xy x0      eq. 3 
providing an accurate estimation of the effect of x on y. 
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The problem of noncompliance 
 Unfortunately this simple solution breaks down in face of noncompliance to 
randomly allocated treatment. Noncompliance creates a disjunction or imperfect correlation 
between the treatment prescribed and the treatment actually received. This disconnect is 
represented in Figure 2 by introducing a new variable, d for dose received (2).  The causal 
effect of treatment x on y is now mediated by d. If noncompliance is random, that is, 
independent of treatment allocation, confounding variables are not introduced, and 
noncompliance is said to be ignorable. However, “ignorable” noncompliance is still 
problematic, as the average difference in the outcome between treatment groups is smaller 
than it might have been under full compliance. This is a form of misclassification bias. That 
is, patients in the treatment group have in fact received no treatment, and the outcome is 
biased toward the null hypothesis of no difference between groups. 
Moreover, perhaps the more common scenario is for non-compliant patients to differ 
in some meaningful way with respect to treatment and outcome (2; 3; 5). This reintroduces 
confounding into the model such that the effect of dose on y is obscured by the pattern of 
noncompliance and its correlation with confounding influences (2; 3). For example, 
noncompliance may be higher in groups of low socioeconomic status (SES), which in turn is 
associated with poorer health outcomes generally. The implication is that the effect of dose 
on y will be confounded by SES in patients who do not receive the assigned treatment and 
happen to have poorer outcomes related to other environmental considerations.  
Estimating effect size in the face of noncompliance 
Common approaches to noncompliance can be grouped in familiar terms as 
estimation of efficacy or of effectiveness (6). As a brief review, the term effectiveness refers 
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to translational impact of a treatment. An estimate of effectiveness seeks to answer the 
question most relevant to the clinician: “What is the effect of prescribing the treatment to my 
patient?” Clearly such an estimate must account for the reality that patients do not always 
comply with prescription, and that the average treatment effectiveness across all patients will 
be diminished by the proportion of noncompliance (6). Conversely, the term efficacy denotes 
the physiological effect of a treatment. It answers the question of most interest to the 
scientist, “what is the effect of receiving the treatment?” or, “what is the physiologic 
response to the treatment?” (5; 6). In terms of the model we have defined so far, efficacy 
represents the causal effect of dose on outcome. (Note that aside from compliance, additional 
considerations are relevant to the distinction between effectiveness and efficacy, but these are 
beyond our present scope; see (7; 8) for a discussion). 
The intent-to-treat (ITT) estimator is the accepted standard for estimating treatment 
effect (6; 9). The name indicates analysis based on the intended, or assigned dose rather than 
the dose actually received. In the face of noncompliance, the variable d (dose received) is 
ignored, and the treatment effect is estimated as the difference in y between randomly 
assigned treatment and control patients. In terms of our causal model, the ITT estimator is the 
difference in y predicted by x, without respect to d. Should the treatment arm include some 
patients who take less than the assigned dose, and/or some control patients receive more than 
the assigned dose, the ITT estimate will be diluted and conservative (2; 9).  
In spite of this problem, ITT analysis is the preferred method because the original 
benefits of randomization remain intact. All patients are analyzed as randomized, precluding 
any correlation between x and w, if not between w and d. When noncompliance occurs, ITT 
will generally produce a conservative estimator of efficacy (3; 10). Moreover, under the 
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assumption that the proportion of noncompliance in the sample reflects the noncompliance 
that would be observed in a general population being prescribed the treatment, the ITT 
estimator is an unbiased measure of effectiveness (6). From this perspective, the statistic is 
very useful to public health officials or policymakers who wish to predict the average benefit 
of promoting a treatment to the population at large. 
In terms of efficacy, three alternative estimators have been described (10). These are 
designed to emphasize the causal effect of dose, rather than randomly assigned treatment per 
se. The as treated (AT) estimator describes the change in y that is predicted by the dose 
actually received, irrespective of randomization. Because randomization to a treatment group 
is discarded in favor of the dose actually received, the estimator is in theory an estimate of 
efficacy. However we have also discarded the principal benefit of randomization: protection 
from confounding. As set out above, any factor correlated with both noncompliance and 
outcome will confound the estimate. In fact, the AT estimate more nearly resembles the 
observational cohort study design, in which exposure (dose) is longitudinally correlated to 
outcome. The use of this estimator may be informative, but its result cannot be properly 
considered a randomized, controlled trial, and is easily confounded by unmeasured variables. 
A second and more common approach to efficacy is the per protocol (PP) estimator. 
The name refers to estimating the effect of the treatment protocol assigned, but only among 
compliant patients. Non-compliant patients are dropped from the data set and treated as 
though patients had withdrawn from the study. As a result, dose received is identical to dose 
prescribed in each treatment arm, and the difference in y between groups is, in theory, an 
accurate estimate of treatment efficacy. In treating noncompliant data as missing, however, 
we encounter the same potential sampling bias arising with any form of missing data (11; 9). 
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That is, any variable associated with both exclusion criteria (noncompliance) and outcomes 
will result in sampling bias and, again, confound the estimate. Although this bias may be 
easier to correct than that observed under AT analyses (11) PP estimators still lack the full 
benefit of randomization, since data have been excluded by non-random criteria.  
Clearly noncompliance shrouds efficacy insofar as dose received is not random, but 
correlated with any confounder characterizing the non-compliant patient. Effectiveness may 
be estimated by ITT analysis where assumptions of generalizability are met. ITT is also 
accepted as a more conservative estimate compared to AT and PP analyses, and less prone to 
type I error. 
Instrumental variables for estimating efficacy 
 For the scientist, the question of efficacy persists because it speaks more to 
mechanism than the alternative. Likewise, the clinician benefits from being able to tell the 
patient how large a difference may be expected if a treatment is taken faithfully. Answers to 
these questions can be approximated using an alternative method of effect size estimation. 
Instrumental variable (IV) analysis originated as a way to isolate the effects of two closely 
related variables (or more technically, to correctly estimate effects of variables whose errors 
are correlated with the error of the dependent variable (1). An instrumental variable, z, is 
defined as one which is correlated with the independent but not the dependent variable; that 
is, the instrument is only correlated with y indirectly by way of its association with the 
independent variable. This variable can be used as an instrument to isolate or purify the 
estimate of effect size.  
 As a practical nutritional example of the procedure, we have applied IV analysis to a 
clinical trial of the effect of a higher protein diet (PRO) compared to a conventional higher 
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carbohydrate diet (CARB) on bone density in 62 adults. The results of this trial were 
originally published in the Journal of Nutrition in June 2008 (12), using only ITT analysis. In 
order to illustrate IV analysis here, we simplify the analysis by ignoring other important 
statistical considerations, such as missing data and multiple follow-up assessments.  
A randomized clinical trial offers an ideal setting for implementation of IV analysis. 
We are interested in efficacy, or the effect of protein “dose” on bone mineral density (BMD). 
Confounding variables collectively represented as w are correlated with d and y, due to 
unique characteristics of noncompliant patients. The assigned treatment x, diet group, 
becomes our instrument, and since it was assigned by randomization, we are confident that it 
is not correlated with y or w except through its influence on protein dose. The assumptions of 
the IV approach are met, and we can now use x to purify the estimate of the causal effect of 
dose on y.  
Subjects and Methods 
 Adults, n=130 (59 males), aged 46±9y were randomized to PRO and CARB 
treatments using a parallel-arm design. Participants were excluded based on medical history 
of smoking, cancer, heart disease, frank diabetes, renal disease or use of bone active 
medications. Patients were block-randomized following matching by age and BMI into 
isocaloric PRO and CARB weight loss diets, designed to achieve roughly 10% weight loss 
over 4 mo, then maintain weight for an additional 8 mo. The CARB diet was modeled on the 
Food Guide Pyramid, prescribing ~15% of energy as protein and 30% as fat. The PRO diet 
substituted some lean meats and dairy for starchy staples, prescribing roughly 30% energy as 
protein and 30% as fat. Patients were instructed in keeping 3-d weighed food records and met 
weekly with a registered dietitian for diet education and monitoring of diet records. Bone 
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mineral density (BMD) was measured using dual x-ray absorptiometry (DXA; Hologic QDR 
4500A or 4500W). Institutional Review Boards of participating centers reviewed and 
approved all study protocols, which were in accordance with their ethical standards for 
human experimentation. Additional details of the intervention may be found in Thorpe, et al. 
(12).  
 As in many long term weight loss studies (13-15), we experienced substantial attrition 
over the 1 y time course, such that 62 subjects (37 in the PRO arm) remained. For simplicity 
of this example we employ listwise deletion of cases with missing data and restrict our 
analysis to BMD of the total hip at 1 y. Weight loss was similar between groups among 
males and females (p>0.2). To account for baseline variation in BMD, we analyze BMD 
change as a percent of baseline values. This approach has the advantage of adjusting for 
many baseline covariates impacting bone health which are not changed in response to the 
intervention (16). As a result of this adjustment, change scores did not differ according to 
gender or the interaction of gender with treatment group. By using change scores, this 
approach provides a more parsimonious set of variables for the implementation of IV 
analysis. As the measure of dose, we used the continuous variable percent energy consumed 
as protein (pro%), estimated using 3-d weighed food records, to account for any influence of 
energy intake, which was also manipulated by the diet. The distributions of pro% in each 
group are illustrated in Figure 3.  
Statistics: ITT and IV estimates 
The ITT effect was estimated by ordinary least squares regression using a treatment 
dummy code (CHO=0, PRO=1). This estimate ignores dose, and is therefore free from 
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confounding influences correlated with dose, but underestimates the physiologic effect of the 
diet, due to overlap in actual protein intakes between groups (Figure 3). 
 Several approaches to the implementation of IV analysis exist and are reviewed in 
Dunn et al. (9).Perhaps the most conceptually straightforward approach is to use a pair of 
ordinary least squares regression models, using the residuals from the first to adjust the 
estimates of the second (3). Because this approach effectively illustrates the logic of IV 
analysis, it will be emphasized here. First we use regression to predict protein intake based 
on randomly assigned diet dummy codes. We save the residuals from this regression, which 
reflect noncompliance, or that part of variance in protein intake that is not accounted for by 
treatment assignment. This is the share of protein intake that may be correlated with 
confounding variables. Next, we perform a second regression, predicting BMD using protein 
dose and covarying for the residuals saved from the first regression. By statistically adjusting 
the effect of protein dose for this extra, potentially confounded variation, we have purified 
the effect estimate, or removed the contaminating influence of that part of dose that may be 
confounded. The result is a better approximation of the true causal effect of dose on y than is 
available using ITT, AT or PP analytic approaches.  
 Following this piece-wise implementation of IV analysis, the IV estimate was 
obtained using the two-stage least squares (2SLS) procedure in SPSS (version 16.0, Chicago, 
IL). The 2SLS procedure is specifically designed for IV analysis. The procedure 
simultaneously performs the two part regression sequence described above, yielding an 
identical effect size but slightly adjusted standard errors to account for correlations in the 
data. Comparable procedures are available in most contemporary statistical packages. The 
present example uses continuous dose and outcome variables; however the same process may 
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be applied to categorical dose or outcome using the appropriate logistic regression models (3; 
9). 
Results 
The Table summarizes the effect sizes estimated by the two approaches. The ITT 
statistic is interpreted as the average effect of assignment to the PRO diet on BMD. The IV 
statistic is interpreted as the average effect of the PRO diet among compliant patients (9). 
These standardized estimates translate into a predicted 1.8% benefit to BMD under ITT, or 
2.4% under IV analysis. 
As expected, IV analysis produced a larger effect size than the generally conservative 
ITT statistic. Provided the assumptions of IV analysis are met, this statistic more closely 
estimates physiologic efficacy (effect of dose) of the dietary treatments on bone health. 
Conversely the ITT statistic, if the pattern of noncompliance in the sample is representative 
of the general population, more nearly reflects effectiveness (effect of prescription) on bone 
health. Figure 4 illustrates the results of the IV analysis. Values are standardized regression 
estimates. Although effects of w are unknown, they are uncorrelated with d after adjusting for 
residuals r. 
 Note in the figure that the ITT statistic, 0.35, is the product of the IV estimate (effect 
of d on y) and the effect of treatment assignment x on dose. Conceptually this is because 
noncompliance dilutes the effect of treatment assignment by the proportion of compliance in 
the sample. Accordingly, where compliance is perfect, the effect of x on d is 1 and the ITT 
and IV estimates are identical.  
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Discussion 
 In this data set, the use of IV analysis produced a 33% increase compared to the 
conventional ITT estimate of the causal effect of the higher protein diet on bone density 
during weight loss. The ITT estimate is known to be conservative in the face of 
noncompliance (5), and this offers particular advantages. First, type I error is usually less 
likely under ITT, though at the cost of increased type II error risk. Second, ITT preserves the 
full benefits of randomization, ensuring that treatment x is not correlated with confounders w. 
Additionally, ITT can be used to answer the question, how much benefit was derived in the 
sample on average, without respect to compliance? If the pattern of noncompliance in the 
sample is generalizable to the population of interest, this statistic speaks to the effectiveness 
of the intervention. Despite these favorable properties, the presence of noncompliance makes 
ITT a biased estimate of efficacy, since outcomes in patients receiving no treatment are 
averaged with the rest of the experimental group. This limitation tempers its usefulness 
where the primary research question deals with the physiological effect of the treatment.  
 We have so far taken for granted the validity of measurements of noncompliance in 
this illustrative analysis. In practice this is not a perfect assumption. Intuitively,  patients who 
do not comply with diet prescriptions may not comply with food records or recalls. It is not 
even unheard of for counterfeit packet or pill counts to be engineered by patients who wish to 
maintain a facade of compliance, for reasons of social desirability or fear of losing benefits of 
participation (9). Biochemical indicators or tracers of intake offer one possible solution, 
however even these are not completely unambiguous. For example, a simulation study 
observed that a staggering variety of consumption patterns might explain given blood levels 
using a dual-tracer monitoring approach (17). Specifically, tracer levels might just as easily 
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be produced by excellent compliance in the three days prior to testing as by consistent 
compliance throughout the study period. Frequent or random biochemical tests may resolve 
these difficulties, but add expense and complexity to a trial. The gold standard of compliance 
monitoring is direct observation of each dose by research staff, however this also adds 
expense, complexity and subject burden to a trial, and is often not practical in long term 
studies in free-living subjects.  
Though difficult, compliance measurement is critical to the interpretation of efficacy 
in nutritional RCTs, regardless of the mode of analysis. Recall that even the ITT statistic 
depends on the generalizability of compliance patterns to perform well as an estimate of 
effectiveness. We therefore recommend that RCTs employ at least two alternate methods of 
monitoring compliance, in order to triangulate the true dose. The combination of food 
records or packet counts with some biochemical marker, for example, would allow greater 
confidence in the validity and reliability of compliance measures. 
 We have emphasized that the ITT statistic estimates effectiveness when the pattern of 
noncompliance in the sample is reflective of the general population. Again, in practice, this 
assumption is sometimes untenable. In fact the subpopulation of individuals willing to 
volunteer for clinical trials differs in important ways from the population at large (18, 19). 
They tend to be more health conscious and more likely to comply with treatment 
prescription. In addition, exclusion of patients with multiple health conditions tends to create 
a sample that is healthier on average than the population at large. These differences tend to 
make estimates of treatment effect more conservative, as control participants will have better 
outcomes on average than a truly random, untreated sample (19). On the whole these 
problems are inevitable, as research ethics mandate volunteer participation by way of 
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informed consent. In theory, the ITT statistic as an estimate of effectiveness would be 
improved if no greater efforts were made to maintain compliance in the study than would be 
made in the clinic. Naturally both investigators and funding agencies are eager to maintain 
compliance as much as possible. These caveats should be kept in mind when interpreting the 
ITT statistic. 
 In light of these considerations, we propose the following steps for dealing with 
noncompliance in clinical trials: 1) Noncompliance should be prevented to the greatest extent 
possible, and then measured. The limitations of methods of monitoring compliance should be 
explicitly recognized and taken into account when drawing inference. 2) Having accepted 
some indicator(s) of compliance as roughly accurate, the pattern of noncompliance should be 
explored and described, as it is an important element of interpretation of the data. 3) Once the 
pattern of noncompliance is understood, it should be incorporated into the statistical model. 
In general, the scientific community regards the ITT estimate as the gold standard which 
should serve as the primary hypothesis test for most clinical trials. Reporting the IV statistic 
in addition to the ITT can add valuable information regarding the physiologic efficacy of a 
treatment. 4) Any estimate of treatment effect must be interpreted with appropriate attention 
to its assumptions and any deviation from them. Departures from assumptions, or 
disagreement between significant tests of two estimators, leave us in murky statistical 
territory. This uncomfortable but familiar scenario should be navigated by careful assessment 
of the pattern of noncompliance, which of course requires adequate measurement.  
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Table B.1. Intent-to-treat (ITT) and Instrumental Variable (IV) statistics for the influence of 
protein intake on bone health, with and without adjustment for noncompliance1. 
Statistic Standardized 
estimate 
(95% Confidence 
Interval) 
ITT 0.35 (0.11-0.60) 
IV 0.47 (0.14-0.82) 
 
1 Statistics derived from dummy-coded ordinary least squares (for ITT) and 2 stage least 
squares (for IV) regression models of the influence of a higher protein relative to a 
conventional higher carbohydrate weight loss diet on bone mineral density of the total hip in 
62 middle aged adults. 
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Figure B.1. Confounders w cause part or all of the relationship between x and y. 
 
 
 
 
Figure B.2. The effect of x on y is mediated by dose d, which may be confounded. 
 
 
 
 
Figure B.3. Distributions of protein intake as a percent of total energy. 
 
 
 
 
 
Figure B.4. Schematic of the IV analysis1. 
 
 
 
1 The ITT statistic, 0.35, can be derived as the product of the IV statistic and the effect of 
treatment assignment on dose. 
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